Concentrix (CNXC) 10-Q5 Apr 242024 Q1 Quarterly reportFinancial data

Company Profile

Cover

Cover - shares	3 Months Ended
Cover - shares	Feb. 29, 2024	Mar. 31, 2024
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Feb. 29, 2024
Document Transition Report	false
Entity File Number	001-39494
Entity Registrant Name	CONCENTRIX CORPORATION
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	27-1605762
Entity Address, Address Line Two	Suite 235
Entity Address, Address Line One	39899 Balentine Drive
Entity Address, City or Town	Newark
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	94560
City Area Code	800
Local Phone Number	747-0583
Title of 12(b) Security	Common Stock, par value $0.0001 per share
Trading Symbol	CNXC
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding (in shares)		65,991,915
Amendment Flag	false
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q1
Entity Central Index Key	0001803599
Current Fiscal Year End Date	--11-30

CONSOLIDATED BALANCE SHEETS

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Feb. 29, 2024	Nov. 30, 2023	Feb. 28, 2023	Nov. 30, 2022
Current assets:
Cash and cash equivalents	$ 234,794	$ 295,336
Accounts receivable, net	1,927,644	1,888,890
Other current assets	619,483	674,423
Total current assets	2,781,921	2,858,649
Property and equipment, net	730,242	748,691
Goodwill	5,030,656	5,078,668	$ 2,905,078	$ 2,904,402
Intangible assets, net	2,672,636	2,804,965
Deferred tax assets	76,088	72,333
Other assets	951,316	928,521
Total assets	12,242,859	12,491,827
Current liabilities:
Accounts payable	202,362	243,565
Current portion of long-term debt	2,714	2,313
Accrued compensation and benefits	594,341	731,172
Other accrued liabilities	923,744	1,016,406
Income taxes payable	59,605	80,583
Total current liabilities	1,782,766	2,074,039
Long-term debt, net	5,034,109	4,939,712
Other long-term liabilities	938,435	920,536
Deferred tax liabilities	385,912	414,246
Total liabilities	8,141,222	8,348,533
Commitments and contingencies (Note 14)
Stockholders’ equity:
Preferred stock, $0.0001 par value, 10,000 shares authorized and no shares issued and outstanding as of February 29, 2024 and November 30, 2023, respectively	0	0
Common stock, $0.0001 par value, 250,000 shares authorized; 52,058 and 51,927 shares issued as of May 31, 2022 and November 30, 2021, respectively, and 51,342 and 51,594 shares outstanding as of May 31, 2022 and November 30, 2021, respectively	7	7
Additional paid-in capital	3,605,694	3,582,521
Treasury stock, 716 and 333 shares as of May 31, 2022 and November 30, 2021, respectively	(295,732)	(271,968)
Retained earnings	1,055,950	1,024,461
Accumulated other comprehensive loss	(264,282)	(191,727)
Total stockholders’ equity	4,101,637	4,143,294	$ 2,800,501	$ 2,695,904
Total liabilities and stockholders’ equity	$ 12,242,859	$ 12,491,827

CONSOLIDATED BALANCE SHEETS (Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Thousands	Feb. 29, 2024	Nov. 30, 2023
Statement of Financial Position [Abstract]
Preferred stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, shares authorized (in shares)	10,000,000	10,000,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized (in shares)	250,000,000	250,000,000
Common stock, shares issued (in shares)	67,981,000	67,883,000
Common stock, shares outstanding (in shares)	65,572,000	65,734,000
Treasury Stock, Common, Shares	2,409,000	2,149,000
Commitments and contingencies (Note 14)
Cash and cash equivalents	234,794	295,336
Accounts receivable, net	1,927,644	1,888,890
Other current assets	619,483	674,423
Total current assets	2,781,921	2,858,649
Property and equipment, net	730,242	748,691
Goodwill	5,030,656	5,078,668
Total	2,672,636	2,804,965
Deferred tax assets	76,088	72,333
Other assets	951,316	928,521
Total assets	12,242,859	12,491,827
Accounts payable	202,362	243,565
Current portion of long-term debt	2,714	2,313
Accrued compensation and benefits	594,341	731,172
Other accrued liabilities	923,744	1,016,406
Income taxes payable	59,605	80,583
Total current liabilities	1,782,766	2,074,039
Long-term debt, net	5,034,109	4,939,712
Other long-term liabilities	938,435	920,536
Deferred tax liabilities	385,912	414,246
Total liabilities	8,141,222	8,348,533
Preferred stock, $0.0001 par value, 10,000 shares authorized and no shares issued and outstanding as of February 29, 2024 and November 30, 2023, respectively	0	0
Common stock, $0.0001 par value, 250,000 shares authorized; 52,058 and 51,927 shares issued as of May 31, 2022 and November 30, 2021, respectively, and 51,342 and 51,594 shares outstanding as of May 31, 2022 and November 30, 2021, respectively	7	7
Additional paid-in capital	3,605,694	3,582,521
Treasury stock, 716 and 333 shares as of May 31, 2022 and November 30, 2021, respectively	(295,732)	(271,968)
Retained earnings	1,055,950	1,024,461
Accumulated other comprehensive loss	(264,282)	(191,727)
Total stockholders’ equity	4,101,637	4,143,294
Total liabilities and stockholders’ equity	$ 12,242,859	$ 12,491,827

CONSOLIDATED STATEMENTS OF OPER

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Feb. 29, 2024	Feb. 28, 2023
Income Statement [Abstract]
Revenue	$ 2,402,748	$ 1,636,404
Cost of revenue	1,546,219	1,055,243
Gross profit	856,529	581,161
Selling, general and administrative expenses	708,090	425,114
Operating income	148,439	156,047
Interest expense and finance charges, net	82,439	33,990
Other expense (income), net	(6,824)	3,714
Income before income taxes	72,824	118,343
Provision for income taxes	20,722	30,473
Net Income (Loss) Attributable to Parent, Total	$ 52,102	$ 87,870
Earnings per common share:
Basic (in dollars per share)	$ 0.76	$ 1.69
Diluted (in dollars per share)	$ 0.76	$ 1.68
Weighted-average common shares outstanding:
Basic (in shares)	65,664	51,150
Diluted (in shares)	65,790	51,476

CONSOLIDATED STATEMENTS OF COMP

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($) $ in Thousands	3 Months Ended
	Feb. 29, 2024	Feb. 28, 2023
Statement of Comprehensive Income [Abstract]
Net income	$ 52,102	$ 87,870
Other comprehensive income (loss):
Unrealized gains (losses) of defined benefit plans, net of taxes of $(135) and $109 for the three months ended February 29, 2024 and February 28, 2023, respectively	1,304	(552)
Unrealized gains (losses) on hedges during the period, net of taxes of $1,328 and $(2,549) for the three months ended February 29, 2024 and February 28, 2023, respectively	(4,020)	7,654
Reclassification of net (gains) losses on hedges to net income, net of taxes of $150 and $(1,934) for the three months ended February 29, 2024 and February 28, 2023, respectively	(427)	5,807
Total change in unrealized gains (losses) on hedges, net of taxes	(4,447)	13,461
Foreign currency translation, net of taxes of $0 for the three months ended February 29, 2024 and February 28, 2023, respectively	(69,412)	17,243
Other comprehensive income (loss)	(72,555)	30,152
Comprehensive income (loss)	$ (20,453)	$ 118,022

CONSOLIDATED STATEMENTS OF CO_2

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Parenthetical) - USD ($) $ in Thousands	3 Months Ended
	Feb. 29, 2024	Feb. 28, 2023
Statement of Comprehensive Income [Abstract]
Change in unrealized losses of defined benefit plans, tax	$ (135)	$ 109
Unrealized gains (losses) on cash flow hedges, tax	(1,328)	2,549
Reclassification of net loss on cash flow hedges to net income, tax	150	(1,934)
Foreign currency translation gain (loss), tax	$ 0	$ 0

CONSOLIDATED STATEMENTS OF STOC

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Common stock	Additional paid-in capital	Retained earnings	Accumulated other comprehensive income (loss)	Treasury Stock, Common
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock, shares outstanding (in shares)		52,367,000				1,271,000
Beginning Balance at Nov. 30, 2022	$ 2,695,904	$ 5	$ 2,428,313	$ 774,114	$ (315,749)	$ (190,779)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Other comprehensive income (loss)	30,152				30,152
Share-based compensation activity (in shares)		228,000
Share-based compensation activity	19,105		19,105
Repurchase of common stock for tax withholdings on equity awards (in shares)						58,000
Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation	(8,216)					$ (8,216)
Repurchase of common stock (in shares)						71,000
Treasury Stock, Value, Acquired, Par Value Method	(10,001)					$ (10,001)
Dividends	(14,313)			(14,313)
Net Income (Loss)	87,870			87,870
Ending Balance at Feb. 28, 2023	$ 2,800,501	$ 5	2,447,418	847,671	(285,597)	$ (208,996)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock, shares outstanding (in shares)		52,595,000				1,400,000
Common stock, shares outstanding (in shares)	65,734,000	67,883,000				2,149,000
Beginning Balance at Nov. 30, 2023	$ 4,143,294	$ 7	3,582,521	1,024,461	(191,727)	$ (271,968)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Other comprehensive income (loss)	(72,555)				(72,555)
Share-based compensation activity (in shares)		98,000
Share-based compensation activity	23,173		23,173
Repurchase of common stock for tax withholdings on equity awards (in shares)						23,000
Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation	(2,090)					$ (2,090)
Repurchase of common stock (in shares)						237,000
Treasury Stock, Value, Acquired, Par Value Method	(21,674)					$ (21,674)
Dividends	(20,613)			(20,613)
Net Income (Loss)	52,102			52,102
Ending Balance at Feb. 29, 2024	$ 4,101,637	$ 7	$ 3,605,694	$ 1,055,950	$ (264,282)	$ (295,732)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock, shares outstanding (in shares)	65,572,000	67,981,000				2,409,000

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended
	Feb. 29, 2024	Feb. 28, 2023
Cash flows from operating activities:
Net income before non-controlling interest	$ 52,102	$ 87,870
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Depreciation	67,758	38,175
Amortization	116,302	39,260
Non-cash share-based compensation expense	21,566	16,601
Provision for doubtful accounts	(180)	1,722
Deferred income taxes	(22,131)	(7,393)
Amortization of debt issuance costs	5,625	419
Pension and other post-retirement benefit costs	3,579	2,934
Pension and other post-retirement plan contributions	(859)	(615)
Change in acquisition contingent consideration	(14,897)	0
Other	(96)	433
Changes in operating assets and liabilities:
Accounts receivable, net	(44,894)	112
Accounts payable	(36,516)	(9,672)
Other operating assets and liabilities	(194,229)	(65,953)
Net cash provided by (used in) operating activities	(46,870)	103,893
Cash flows from investing activities:
Purchases of property and equipment	(56,059)	(39,597)
Acquisition of business, net of cash and restricted cash acquired	(4,503)	0
Net cash used in investing activities	(60,562)	(39,597)
Cash flows from financing activities:
Proceeds from the Amended Credit Facility - Term Loan	0	0
Proceeds from the Securitization Facility	628,000	417,500
Repayments of the Securitization Facility	(430,500)	(397,000)
Proceeds from Other Debt	400	0
Repayments of Other Debt	(2,792)	0
Proceeds from exercise of stock options	1,607	2,504
Repurchase of common stock for tax withholdings on equity awards	(2,090)	(8,216)
Repurchase of common stock	(21,674)	(10,001)
Dividends paid	(20,613)	(14,313)
Change in funds held for clients	(37,894)	0
Net cash provided by (used in) financing activities	14,444	(34,526)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	(5,544)	2,797
Net increase (decrease) in cash, cash equivalents and restricted cash	(98,532)	32,567
Cash, cash equivalents and restricted cash at beginning of year	516,487	157,463
Cash, cash equivalents and restricted cash at end of period	417,955	190,030
Supplemental disclosure of non-cash investing activities:
Accrued costs for property and equipment purchases	20,181	5,747
Prior Credit Facility - Term Loan
Cash flows from financing activities:
Repayments of the Amended Credit Facility - Term Loan	$ (100,000)	$ (25,000)

BACKGROUND AND BASIS OF PRESENT

BACKGROUND AND BASIS OF PRESENTATION	3 Months Ended
BACKGROUND AND BASIS OF PRESENTATION	Feb. 29, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
BACKGROUND AND BASIS OF PRESENTATION	BACKGROUND AND BASIS OF PRESENTATION: Background Concentrix Corporation (“Concentrix,” the “CX business” or the “Company”), is a leading global provider of Customer Experience (“CX”) solutions and technology that help iconic and disruptive brands drive deep understanding, full lifecycle engagement, and differentiated experiences for their end-customers around the world. The Company provides end-to-end capabilities, including CX process optimization, technology innovation and design engineering, front- and back-office automation, analytics, and business transformation services to clients in five primary industry verticals. The Company’s primary verticals are technology and consumer electronics, retail, travel and e-commerce, communications and media, banking, financial services and insurance, and healthcare. Basis of presentation The accompanying interim unaudited consolidated financial statements have been prepared by the Company in accordance with the rules and regulations of the Securities and Exchange Commission (“SEC”). The amounts as of November 30, 2023 have been derived from the Company’s annual audited financial statements included in the Company’s Annual Report on Form 10-K for the fiscal year ended November 30, 2023. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles (“GAAP”) in the United States have been condensed or omitted in accordance with such rules and regulations. In the opinion of management, the accompanying unaudited consolidated financial statements reflect all adjustments, consisting only of normal recurring adjustments, necessary to state fairly the financial position of the Company and its results of operations and cash flows as of and for the periods presented. These interim consolidated financial statements should be read in conjunction with the annual audited financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended November 30, 2023. All intercompany balances and transactions have been eliminated in consolidation. Reclassifications Certain amounts in the consolidated financial statements related to the prior years have been reclassified to conform to the current year’s presentation.

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	3 Months Ended
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	Feb. 29, 2024
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES: For a discussion of the Company’s significant accounting policies, refer to the Company’s Annual Report on Form 10-K for the fiscal year ended November 30, 2023. Recently adopted accounting pronouncements are discussed below. Concentration of credit risk For the three months ended February 29, 2024 and February 28, 2023, no client accounted for more than 10% of the Company’s consolidated revenue. As of February 29, 2024 and November 30, 2023, no client comprised more than 10% of the Company’s total accounts receivable balance. Recently adopted accounting pronouncements In November 2023, the Financial Accounting Standards Board (the “FASB”) issued accounting standards update (“ASU”) 2023-07, which enhances the disclosures required for reportable segments in annual and interim consolidated financial statements. ASU 2023-07 is effective for the Company for annual reporting periods beginning with the fiscal year ending November 30, 2025 and for interim reporting periods beginning in fiscal year 2026. Early adoption is permitted. The Company is currently evaluating the impact that this update will have on its disclosures in the consolidated financial statements. In December 2023, the FASB issued ASU 2023-09, which requires enhanced income tax disclosures, including disaggregation of information in the rate reconciliation table and disaggregated information related to income taxes paid. The amendments in ASU 2023-09 are effective for the fiscal year ending November 30, 2026. The Company is currently evaluating the impact that this update will have on its disclosures in the consolidated financial statements.

ACQUISITION

ACQUISITION	3 Months Ended
ACQUISITION	Feb. 29, 2024
Business Combination and Asset Acquisition [Abstract]
ACQUISITION	NOTE 3—ACQUISITIONS: Webhelp Combination Background On September 25, 2023, the Company completed its acquisition (the “Webhelp Combination”) of all of the issued and outstanding capital stock (the “Shares”) of Marnix Lux SA, a public limited liability company ( société anonyme ) incorporated under the laws of the Grand Duchy of Luxembourg (“Webhelp Parent”) and the parent company of the Webhelp business (“Webhelp”), from the holders thereof (the “Sellers”). The Webhelp Combination was completed pursuant to the terms and conditions of the Share Purchase and Contribution Agreement, dated as of June 12, 2023, as amended by the First Amendment to the Share Purchase and Contribution Agreement, dated as of July 14, 2023 (the “SPA”), by and among Concentrix, OSYRIS S.à r.l., a private limited liability company ( société à responsabilité limitée ) incorporated under the laws of the Grand Duchy of Luxembourg and a direct wholly owned subsidiary of Concentrix Corporation (“Purchaser”), Webhelp Parent, the Sellers, and certain representatives of the Sellers. Webhelp is a leading provider of CX solutions, including sales, marketing, and payment services, with significant operations and client relationships in Europe, Latin America, and Africa. Since the closing of the Webhelp Combination, the Company has operated under the trade name “Concentrix + Webhelp” while it transitions Webhelp operations and branding to the Concentrix name. Preliminary purchase price consideration The total preliminary purchase price consideration, net of cash and restricted cash acquired, for the acquisition of Webhelp was $3,774.8 million, which was funded by proceeds from the Company’s August 2023 offering and sale of senior notes, term loan borrowings under the Company’s senior credit facility, the issuance of shares of the Company’s common stock, and cash on hand. See Note 8 — Borrowings for a further discussion of the Company’s senior notes, term loan, and senior credit facility. The preliminary purchase price consideration to acquire Webhelp consisted of the following: Cash consideration for Shares (1) $ 529,160 Cash consideration for repayment of Webhelp debt and shareholder loan (2) 1,915,197 Total cash consideration 2,444,357 Equity consideration (3) 1,084,894 Earnout shares contingent consideration (4) 32,919 Sellers’ note consideration (5) 711,830 Total consideration transferred 4,274,000 Less: Cash and restricted cash acquired (6) 499,211 Total purchase price consideration $ 3,774,789 (1) Represents the cash consideration paid, and to be paid, in the aggregate amount of €500,000, as adjusted in accordance with the SPA. (2) Represents the cash consideration paid to repay Webhelp’s outstanding senior loan debt and shareholder loan. (3) Represents the issuance of 14,862 shares of common stock, par value $0.0001 per share, of Concentrix Corporation (the “Concentrix common stock”). (4) Represents the contingent right for the Sellers to earn an additional 750 shares of Concentrix common stock (the “Earnout Shares”). The estimated fair value of this contingent consideration was determined using a Monte-Carlo simulation model. The inputs include the closing price of Concentrix common stock as of the Closing Date, Concentrix-specific historical equity volatility, and the risk-free rate. See further details below. (5) Represents a promissory note issued by Concentrix Corporation in the aggregate principal amount of €700,000 to certain Sellers. See Note 8 — Borrowings for a further discussion of this promissory note. (6) Represents the Webhelp cash and restricted cash balance acquired at the Closing Date. The Company granted Sellers the contingent right to earn the Earnout Shares if certain conditions set forth in the SPA occur, including the share price of Concentrix common stock reaching $170.00 per share within seven years from the closing of the Webhelp Combination (the “Closing Date”) (based on daily volume weighted average prices measured over a specified period). Prior to the Closing Date, Concentrix and certain Sellers entered into stock restriction agreements (the “Stock Restriction Agreements”), pursuant to which such Sellers (the “Restricted Stock Participants”) agreed to contribute in kind to the Company, and the Company agreed to receive, certain of the Restricted Stock Participants’ Shares in exchange for the issuance of shares of Concentrix common stock with certain restrictions thereon (the “Restricted Shares”) in lieu of such Sellers’ right to a portion of the Earnout Shares. On the Closing Date, the Company issued approximately 80 Restricted Shares in exchange for certain of the Restricted Stock Participants’ Shares. The Restricted Shares are non-transferable and non-assignable and are not entitled to any dividends or distributions unless and until the restrictions lapse, as set forth in the Stock Restriction Agreements. The Restricted Shares will be automatically cancelled by the Company for no consideration in the event that the restrictions on the Restricted Shares do not lapse. The Restricted Stock Participants have waived any and all rights as a holder of Restricted Shares to vote on any matter submitted to the holders of Concentrix common stock. Preliminary purchase price allocation The acquisition was accounted for as a business combination in accordance with Accounting Standards Codification (“ASC”) Topic 805, Business Combinations . The purchase price was allocated to the assets acquired and liabilities assumed based on management’s estimate of the respective fair values at the date of acquisition. Goodwill was calculated as the excess of the consideration transferred over the net assets recognized and represents the estimated future economic benefits arising from other assets acquired that could not be individually identified and separately recognized. The factors contributing to the recognition of goodwill were the assembled workforce, comprehensive service portfolio delivery capabilities, and strategic benefits that are expected to be realized from the acquisition. None of the goodwill is expected to be deductible for income tax purposes. The following table summarizes the preliminary fair values of the assets acquired and liabilities assumed as of the acquisition date: As of September 25, 2023 Assets acquired: Cash and cash equivalents $ 310,313 Accounts receivable 455,218 Other current assets (1) 454,465 Property and equipment 323,606 Identifiable intangible assets 1,984,000 Goodwill 2,098,531 Deferred tax assets 22,541 Other assets 410,085 6,058,759 Liabilities assumed: Accounts payable 67,558 Accrued compensation and benefits 246,450 Other accrued liabilities 576,549 Income taxes payable 72,227 Debt (current portion and long-term) 8,589 Deferred tax liabilities 411,788 Other long-term liabilities 401,598 Total liabilities assumed 1,784,759 Total consideration transferred $ 4,274,000 (1) Includes restricted cash acquired of $188,899. As of February 29, 2024, the purchase price allocation is preliminary. The preliminary purchase price allocation was based upon a preliminary valuation, and the Company’s estimates and assumptions are subject to change within the measurement period (not to exceed twelve months following the acquisition date). The primary areas of the preliminary purchase price allocation that are not yet finalized relate to the valuation of identifiable intangible assets acquired, the fair value of certain tangible assets acquired and liabilities assumed, and deferred income taxes. The Company expects to continue to obtain information for the purpose of determining the fair value of the assets acquired and liabilities assumed on the acquisition date throughout the remainder of the measurement period. As a result of further refining its estimates and assumptions since the date of the acquisition, the Company recorded measurement period adjustments to the initial purchase price allocation. Adjustments were primarily made to cash, goodwill, accrued compensation and benefits, accrued liabilities and deferred income taxes. These measurement period adjustments to the preliminary purchase price allocation during the three months ended February 29, 2024 were not material. The preliminary purchase price allocation includes $1,984,000 of acquired identifiable intangible assets, all of which have finite lives. The fair value of the identifiable intangible assets has been estimated by using the income approach through a discounted cash flow analysis of certain cash flow projections. The cash flow projections are based on forecasts used by the Company to price the Webhelp Combination, and the discount rates applied were benchmarked by referencing the implied rate of return of the Company’s pricing model and the weighted average cost of capital. The intangible assets are being amortized over their estimated useful lives on either a straight-line basis or an accelerated method that reflects the economic benefit of the asset. The determination of the useful lives is based upon various industry studies, historical acquisition experience, economic factors, and future forecasted cash flows of the Company following the acquisition of Webhelp. The preliminary amounts allocated to intangible assets are as follows: Gross Carrying Amount Weighted-Average Useful Life Amortization Method Customer relationships $ 1,882,000 15 years Accelerated Trade name 102,000 3 years Straight-line Total $ 1,984,000 Supplemental Pro Forma Information (unaudited) The supplemental pro forma financial information presented below is for illustrative purposes only, does not include the pro forma adjustments that would be required under Regulation S-X for pro forma financial information, is not necessarily indicative of the financial position or results of operations that would have been realized if the combination with Webhelp had been completed on December 1, 2022, does not reflect synergies that might have been achieved, nor is it indicative of future operating results or financial position. The pro forma adjustments are based upon currently available information and certain assumptions that the Company believes are reasonable under the circumstances. The supplemental pro forma financial information reflects pro forma adjustments to present the combined pro forma results of operations as if the combination with Webhelp had occurred on December 1, 2022 to give effect to certain events that the Company believes to be directly attributable to the acquisition. These pro forma adjustments primarily include: • A net increase in amortization expense that would have been recognized due to acquired identifiable intangible assets. • An increase in depreciation expense associated with the step up of fair values of property and equipment assets acquired. • A net increase to interest expense to reflect the additional borrowings of Concentrix incurred in connection with the combination as previously described and the repayment of Webhelp’s historical debt in conjunction with the combination. • The related income tax effects of the adjustments noted above. The supplemental pro forma financial information for the prior period first fiscal quarter ended February 28, 2023 is as follows: Three Months Ended February 28, 2023 Revenue $ 2,362,015 Net income 17,482 Acquisition-related and integration expenses

SHARE-BASED COMPENSATION

SHARE-BASED COMPENSATION	3 Months Ended
SHARE-BASED COMPENSATION	Feb. 29, 2024
Share-Based Payment Arrangement [Abstract]
SHARE-BASED COMPENSATION	SHARE-BASED COMPENSATION: The Company recognizes share-based compensation expense for all share-based awards made to employees and directors, including employee stock options, restricted stock awards, restricted stock units, and performance-based restricted stock units based on estimated fair values. In February 2024, the Company granted 96 restricted stock units and 115 performance-based restricted stock units under the Concentrix Stock Incentive Plan, which included annual awards to the Company’s senior executive team. The restricted stock units had a weighted average grant date fair value of $89.28 per share and vest over a service period of three years. The performance-based restricted stock units will vest, if at all, upon the achievement of certain financial targets during the three-year period ending November 30, 2026. The performance-based restricted stock units had a grant date weighted average fair value of $85.71 per share. The Company recorded share-based compensation expense in the consolidated statements of operations for the three months ended February 29, 2024 and February 28, 2023 as follows: Three Months Ended February 29, 2024 February 28, 2023 Total share-based compensation $ 21,646 $ 16,754 Tax benefit recorded in the provision for income taxes (5,411) (4,188) Effect on net income $ 16,235 $ 12,566

BALANCE SHEET COMPONENTS

BALANCE SHEET COMPONENTS	3 Months Ended
BALANCE SHEET COMPONENTS	Feb. 29, 2024
Balance Sheet Related Disclosures [Abstract]
BALANCE SHEET COMPONENTS	BALANCE SHEET COMPONENTS: Cash, cash equivalents and restricted cash: The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the consolidated balance sheets that sum to the total of the same amounts shown in the consolidated statements of cash flows: As of February 29, 2024 November 30, 2023 Cash and cash equivalents $ 234,794 $ 295,336 Restricted cash included in other current assets 183,161 221,151 Cash, cash equivalents and restricted cash $ 417,955 $ 516,487 Restricted cash balances relate primarily to funds held for clients, restrictions placed on cash deposits by banks as collateral for the issuance of bank guarantees and the terms of a government grant, and letters of credit for leases. The Company had a corresponding current liability recorded in other accrued liabilities on the consolidated balance sheet related to funds held for clients of approximately $174,303 and $218,228 as of February 29, 2024 and November 30, 2023, respectively. Accounts receivable, net: Accounts receivable, net is comprised of the following as of February 29, 2024 and November 30, 2023: As of February 29, 2024 November 30, 2023 Billed accounts receivable $ 1,098,480 $ 1,082,469 Unbilled accounts receivable 840,339 818,954 Less: Allowance for doubtful accounts (11,175) (12,533) Accounts receivable, net $ 1,927,644 $ 1,888,890 Allowance for doubtful trade receivables: Presented below is a progression of the allowance for doubtful trade receivables: Three Months Ended February 29, 2024 February 28, 2023 Balance at beginning of period $ 12,533 $ 4,797 Net additions (reductions) (180) 1,722 Write-offs and reclassifications (1,178) (435) Balance at end of period $ 11,175 $ 6,084 Property and equipment, net: The following table summarizes the carrying amounts and related accumulated depreciation for property and equipment as of February 29, 2024 and November 30, 2023: As of February 29, 2024 November 30, 2023 Land $ 28,276 $ 28,039 Equipment, computers and software 777,778 762,961 Furniture and fixtures 157,760 157,425 Buildings, building improvements and leasehold improvements 567,571 566,384 Construction-in-progress 35,869 35,175 Total property and equipment, gross $ 1,567,254 $ 1,549,984 Less: Accumulated depreciation (837,012) (801,293) Property and equipment, net $ 730,242 $ 748,691 Shown below are the countries where 10% or more and other significant concentrations of the Company’s property and equipment, net are located as of February 29, 2024 and November 30, 2023: As of February 29, 2024 November 30, 2023 Property and equipment, net: United States $ 121,875 $ 123,335 Philippines 72,460 75,943 France 70,913 65,599 India 48,895 51,248 Others 416,099 432,566 Total $ 730,242 $ 748,691 Goodwill: The following table summarizes the changes in the Company’s goodwill for the three months ended February 29, 2024 and February 28, 2023: Three Months Ended February 29, 2024 February 28, 2023 Balance at beginning of period $ 5,078,668 $ 2,904,402 Acquisition measurement period adjustments 13,187 — Foreign exchange translation (61,199) 676 Balance at end of period $ 5,030,656 $ 2,905,078 Intangible assets, net: The following tables summarize the carrying amounts and related accumulated amortization for intangible assets as of February 29, 2024 and November 30, 2023: As of February 29, 2024 As of November 30, 2023 Gross amounts Accumulated amortization Net amounts Gross amounts Accumulated amortization Net amounts Customer relationships $ 3,652,193 $ (1,111,685) $ 2,540,508 $ 3,670,246 $ (1,011,201) $ 2,659,045 Technology 79,690 (39,642) 40,048 79,739 (36,174) 43,565 Trade names 117,948 (26,471) 91,477 118,823 (17,255) 101,568 Non-compete agreements 2,200 (1,597) 603 2,200 (1,413) 787 $ 3,852,031 $ (1,179,395) $ 2,672,636 $ 3,871,008 $ (1,066,043) $ 2,804,965 Estimated future amortization expense of the Company’s intangible assets is as follows: Fiscal years ending November 30, 2024 (remaining nine months) $ 344,518 2025 428,418 2026 381,018 2027 288,145 2028 244,272 Thereafter 986,265 Total $ 2,672,636 Accumulated other comprehensive income (loss): The components of accumulated other comprehensive income (loss) (“AOCI”), net of taxes, were as follows: Three Months Ended February 29, 2024 and February 28, 2023 Unrecognized gains (losses) on defined benefit plan, net of taxes Unrealized gains (losses) on hedges, net of taxes Foreign currency translation adjustments, net of taxes Total Balances at November 30, 2022 $ (8,471) $ (19,914) $ (287,364) $ (315,749) Other comprehensive income (loss) before reclassification (552) 7,654 17,243 24,345 Reclassification of losses from other comprehensive income (loss) — 5,807 — 5,807 Balances at February 28, 2023 $ (9,023) $ (6,453) $ (270,121) $ (285,597) Balances at November 30, 2023 $ (11,271) $ 4,489 $ (184,945) $ (191,727) Other comprehensive income (loss) before reclassification 1,304 (4,020) (69,412) (72,128) Reclassification of gains from other comprehensive income (loss) — (427) — (427) Balances at February 29, 2024 $ (9,967) $ 42 $ (254,357) $ (264,282)

DERIVATIVE INSTRUMENTS

DERIVATIVE INSTRUMENTS	3 Months Ended
DERIVATIVE INSTRUMENTS	Feb. 29, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]
DERIVATIVE INSTRUMENTS	DERIVATIVE INSTRUMENTS: In the ordinary course of business, the Company is exposed to foreign currency risk and credit risk. The Company enters into transactions, and owns monetary assets and liabilities, that are denominated in currencies other than the legal entity’s functional currency. The Company may enter into forward contracts, option contracts, or other derivative instruments to offset a portion of the risk on expected future cash flows, earnings, net investments in certain non-U.S. legal entities and certain existing assets and liabilities. However, the Company may choose not to hedge certain exposures for a variety of reasons including, but not limited to, accounting considerations and the economic cost of hedging particular exposures. There can be no assurance the hedges will offset more than a portion of the financial impact resulting from movements in foreign currency exchange or interest rates. Generally, the Company does not use derivative instruments to cover equity risk and credit risk. The Company’s hedging program is not used for trading or speculative purposes. All derivatives are recognized on the consolidated balance sheets at their fair values. Changes in the fair value of derivatives are recorded in the consolidated statements of operations, or as a component of AOCI in the consolidated balance sheets, as discussed below. Cash Flow Hedges To protect gross margins from fluctuations in foreign currency exchange rates, certain of the Company’s legal entities with functional currencies that are not U.S. dollars may hedge a portion of forecasted revenue or costs not denominated in the entities’ functional currencies. These instruments mature at various dates through February 2026. Gains and losses on cash flow hedges are recorded in AOCI until the hedged item is recognized in earnings. Deferred gains and losses associated with cash flow hedges of foreign currency revenue are recognized as a component of “Revenue” in the same period as the related revenue is recognized, and deferred gains and losses related to cash flow hedges of foreign currency costs are recognized as a component of “Cost of revenue” or “Selling, general and administrative expenses” in the same period as the related costs are recognized. Derivative instruments designated as cash flow hedges must be de-designated as hedges when it is probable the forecasted hedged transaction will not occur in the initially identified time period or within a subsequent two-month time period. Deferred gains and losses in AOCI associated with such derivative instruments are reclassified into earnings in the period of de-designation. Any subsequent changes in fair value of such derivative instruments are recorded in earnings unless they are re-designated as hedges of other transactions. Non-Designated Derivatives The Company uses short-term forward contracts to offset the foreign exchange risk of assets and liabilities denominated in currencies other than the functional currencies of the Company’s legal entities that own the assets or liabilities. These contracts, which are not designated as hedging instruments, mature or settle within twelve months. Derivatives that are not designated as hedging instruments are adjusted to fair value through earnings in the financial statement line item to which the derivative relates. Cross-currency interest rate swaps In connection with the closing of the Webhelp Combination, the Company entered into cross-currency swap arrangements with certain financial institutions for a total notional amount of $500,000 of the Company’s senior notes. In addition to aligning the currency of a portion of the Company’s interest payments to the Company’s euro-denominated cash flows, the arrangements, together with intercompany loans and additional intercompany cross-currency interest rate swap arrangements described below, effectively converted $250,000 aggregate principal amount of the Company’s 6.650% Senior Notes due 2026 and $250,000 aggregate principal amount of the Company’s 6.660% Senior Notes due 2028 into synthetic fixed euro-based debt at weighted average interest rates of 5.12% and 5.18%, respectively. Concurrent with entering into the cross-currency interest rate swaps with certain financial institutions, Marnix SAS, a wholly owned subsidiary of Concentrix, entered into corresponding U.S. dollar denominated intercompany loan agreements with certain other subsidiaries of Concentrix with identical terms and notional amounts as the underlying $500,000 U.S. dollar denominated senior notes, with reciprocal cross currency interest rate swaps. The cross-currency interest rate swaps are designated as fair value hedges. Fair Values of Derivative Instruments in the Consolidated Balance Sheets The fair values of the Company’s derivative instruments are disclosed in Note 7—Fair Value Measurements and summarized in the table below: Value as of Balance Sheet Line Item February 29, 2024 November 30, 2023 Derivative instruments not designated as hedging instruments: Foreign exchange forward contracts (notional value) $ 1,478,401 $ 2,173,330 Other current assets 10,519 16,078 Other accrued liabilities 9,556 20,856 Derivative instruments designated as fair value hedges: Cross-currency interest rate swaps (notional value) $ 471,604 $ 471,604 Other long-term liabilities 12,988 17,219 Derivative instruments designated as cash flow hedges: Foreign exchange forward contracts (notional value) $ 1,013,034 $ 996,667 Other current assets and other assets 9,849 14,330 Other accrued liabilities and other long-term liabilities 4,244 2,724 Volume of activity The notional amounts of foreign exchange forward contracts represent the gross amounts of foreign currency, including, principally, the Philippine peso, the Indian rupee, the euro, the British pound, the Canadian dollar, the Japanese yen, and the Australian dollar, that will be bought or sold at maturity. The notional amounts for outstanding derivative instruments provide one measure of the transaction volume outstanding and do not represent the amount of the Company’s exposure to credit or market loss. The Company’s exposure to credit loss and market risk will vary over time as currency exchange rates change. The Effect of Derivative Instruments on AOCI and the Consolidated Statements of Operations The following table shows the gains and losses, before taxes, of the Company’s derivative instruments designated as cash flow hedges and not designated as hedging instruments in other comprehensive income (“OCI”), and the consolidated statements of operations for the periods presented: Three Months Ended Locations of gain (loss) in statement of operations February 29, 2024 February 28, 2023 Derivative instruments designated as cash flow and fair value hedges: Gains (losses) recognized in OCI: Foreign exchange forward contracts $ (5,423) $ 10,203 Cross-currency interest rate swaps 75 — Total $ (5,348) $ 10,203 Gains (losses) reclassified from AOCI into income: Foreign exchange forward contracts Gain (loss) reclassified from AOCI into income Cost of revenue for services $ 454 $ (5,760) Gain (loss) reclassified from AOCI into income Selling, general and administrative expenses 123 (1,981) Total $ 577 $ (7,741) Derivative instruments not designated as hedging instruments: Gain recognized from foreign exchange forward contracts, net (1) Other expense (income), net $ 337 $ 6,225 (1) The gains and losses largely offset the currency gains and losses that resulted from changes in the assets and liabilities denominated in nonfunctional currencies. There were no material gain or loss amounts excluded from the assessment of effectiveness. Existing net gains in AOCI that are expected to be reclassified into earnings in the normal course of business within the next twelve months are $5,168. Offsetting of Derivatives In the consolidated balance sheets, the Company does not offset derivative assets against liabilities in master netting arrangements. Credit exposure for derivative financial instruments is limited to the amounts, if any, by which the counterparties’ obligations under the contracts exceed the Company’s obligations to the counterparties. The Company manages the potential risk of credit losses through careful evaluation of counterparty credit standing and selection of counterparties from a limited group of financial institutions with high credit standing.

FAIR VALUE MEASUREMENTS

FAIR VALUE MEASUREMENTS	3 Months Ended
FAIR VALUE MEASUREMENTS	Feb. 29, 2024
Fair Value Disclosures [Abstract]
FAIR VALUE MEASUREMENTS	FAIR VALUE MEASUREMENTS: The Company’s fair value measurements are classified and disclosed in one of the following three categories: Level 1: Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities; Level 2: Quoted prices in markets that are not active, or inputs which are observable, either directly or indirectly, for substantially the full term of the asset or liability; and Level 3: Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (i.e., supported by little or no market activity). The following table summarizes the valuation of the Company’s investments and financial instruments that are measured at fair value on a recurring basis: As of February 29, 2024 As of November 30, 2023 Fair value measurement category Fair value measurement category Total Level 1 Level 2 Level 3 Total Level 1 Level 2 Level 3 Assets measured at fair value: Cash equivalents $ 49,236 $ 49,236 $ — $ — $ 52,847 $ 52,847 $ — $ — Foreign government bond — — — — 1,853 1,853 — — Forward foreign currency exchange contracts 20,368 — 20,368 — 30,408 — 30,408 — Liabilities measured at fair value: Forward foreign currency exchange contracts 13,800 — 13,800 — 23,580 — 23,580 — Cross-currency interest rate swaps 12,988 — 12,988 — 17,219 — 17,219 — Acquisition contingent consideration 31,940 — 31,940 — 48,600 — 48,600 — Liabilities measured at other than fair value: Long term debt (senior notes) Fair value 2,149,981 — 2,149,981 — 2,146,554 — 2,146,554 — Carrying amount 2,132,774 — — — 2,131,870 — — — The Company’s cash equivalents consist primarily of highly liquid investments in money market funds and term deposits with maturity periods of three months or less. The carrying values of cash equivalents approximate fair value since they are near their maturity. Investment in foreign government bond classified as an available-for-sale debt security is recorded at fair value based on quoted market prices. The fair values of forward exchange contracts are measured based on the foreign currency spot and forward rates. Fair values of long-term foreign currency exchange contracts are measured using valuations based upon quoted prices for similar assets and liabilities in active markets and are valued by reference to similar financial instruments, adjusted for terms specific to the contracts. The fair values of the cross-currency interest rate swaps are determined using a market approach that is based on observable inputs other than quoted market prices, including contract terms, interest rates, currency rates, and other market factors. The estimated fair value of the acquisition contingent consideration was determined using a Monte-Carlo simulation model. The inputs include the closing price of Concentrix common stock as of the reporting period end date, Concentrix-specific historical equity volatility, and the risk-free rate. The effect of nonperformance risk on the fair value of derivative instruments was not material as of February 29, 2024 and November 30, 2023. The carrying values of term deposits with maturities less than one year, accounts receivable and accounts payable approximate fair value due to their short maturities and interest rates that are variable in nature. The carrying values of the outstanding balance on the term loan under the Company’s senior credit facility and the outstanding balance on the Company’s accounts receivable securitization facility (the “Securitization Facility”) approximate their fair values since they bear interest rates that are similar to existing market rates. The fair values of the 2026 Notes, 2028 Notes, and 2033 Notes (as defined in Note 8) were based on quoted prices in active markets and are classified within Level 2 of the fair value hierarchy. The Company does not adjust the quoted market prices for such financial instruments.

BORROWINGS

BORROWINGS	3 Months Ended
BORROWINGS	Feb. 29, 2024
Debt Disclosure [Abstract]
BORROWINGS	NOTE 8—BORROWINGS: Borrowings consist of the following: As of February 29, 2024 November 30, 2023 Other loans $ 2,714 $ 2,313 Current portion of long-term debt $ 2,714 $ 2,313 6.650% Senior Notes due 2026 $ 800,000 $ 800,000 6.600% Senior Notes due 2028 800,000 800,000 6.850% Senior Notes due 2033 550,000 550,000 Credit Facility - Term Loan component 1,850,000 1,950,000 Securitization Facility 326,000 128,500 Sellers’ Note 756,177 762,286 Other loans 2,509 5,301 Long-term debt, before unamortized debt discount and issuance costs 5,084,686 4,996,087 Less: unamortized debt discount and issuance costs (50,577) (56,375) Long-term debt, net $ 5,034,109 $ 4,939,712 Senior Notes On August 2, 2023, the Company issued and sold (i) $800,000 aggregate principal amount of 6.650% Senior Notes due 2026 (the “2026 Notes”), (ii) $800,000 aggregate principal amount of 6.600% Senior Notes due 2028 (the “2028 Notes”) and (iii) $550,000 aggregate principal amount of 6.850% Senior Notes due 2033 (the “2033 Notes” and, together with the 2026 Notes and 2028 Notes, the “Senior Notes”). The Senior Notes were sold in a registered public offering pursuant to the Company’s Registration Statement on Form S-3, which became effective upon filing, and a Prospectus Supplement dated July 19, 2023, to a Prospectus dated July 17, 2023. The Senior Notes were issued pursuant to, and are governed by, an indenture, dated as of August 2, 2023 (the “Base Indenture”), between Concentrix and U.S. Bank Trust Company, National Association, as trustee (the “Trustee”), as supplemented by a first supplemental indenture dated as of August 2, 2023 between Concentrix and the Trustee relating to the 2026 Notes, a second supplemental indenture dated as of August 2, 2023 between Concentrix and the Trustee relating to the 2028 Notes, and a third supplemental indenture dated as of August 2, 2023 between Concentrix and the Trustee relating to the 2033 Notes (such supplemental indentures, together with the Base Indenture, the “Indenture”). The Indenture contains customary covenants and restrictions, including covenants that limit Concentrix Corporation’s and certain of its subsidiaries’ ability to create or incur liens on shares of stock of certain subsidiaries or on principal properties, engage in sale/leaseback transactions or, with respect to Concentrix Corporation, consolidate or merge with, or sell or lease substantially all its assets to, another person. The Indenture also provides for customary events of default. Restated Credit Facility On April 21, 2023, the Company entered into an Amendment and Restatement Agreement (the “Amendment Agreement”) with the lenders party thereto, JPMorgan Chase Bank, N.A. and Bank of America, N.A., to amend and restate the Company’s senior secured credit facility (the “Prior Credit Facility” and as amended and restated, the “Restated Credit Facility”). The Restated Credit Facility provides for the extension of a senior unsecured revolving credit facility not to exceed an aggregate principal amount of $1,042,500. The Restated Credit Facility also provides for a senior unsecured term loan facility in an aggregate principal amount not to exceed approximately $2,144,700 (the “Term Loan”), of which $1,850,000 was incurred upon the amendment and approximately $294,702 was drawn on a delayed draw basis on the Closing Date. Aggregate borrowing capacity under the Restated Credit Facility may be increased by up to an additional $500,000 by increasing the amount of the revolving credit facility or by incurring additional term loans, in each case subject to the satisfaction of certain conditions set forth in the Restated Credit Facility, including the receipt of additional commitments for such increase. As of November 30, 2023, the outstanding principal balance on the Term Loan was $1,950,000 due to principal payments made subsequent to the Closing Date. During the three months ended February 29, 2024, the Company voluntarily prepaid $100,000 of the principal balance on the Term Loan, without penalty, resulting in an outstanding balance at February 29, 2024 of $1,850,000. The maturity date of the Restated Credit Facility is December 27, 2026, subject, in the case of the revolving credit facility, to two one-year extensions upon the Company’s prior notice to the lenders and the agreement of the lenders to extend such maturity date. Due to the voluntary prepayments previously described, no principal payment is required until the outstanding principal amount is due in full on the maturity date. Borrowings under the Restated Credit Facility bear interest, in the case of SOFR rate loans, at a per annum rate equal to the applicable SOFR rate (but not less than 0.0%), plus an applicable margin, which ranges from 1.125% to 2.000%, based on the credit ratings of the Company’s senior unsecured non-credit enhanced long-term indebtedness for borrowed money plus a credit spread adjustment to the SOFR rate of 0.10%. Borrowings under the Restated Credit Facility that are base rate loans bear interest at a per annum rate (but not less than 1.0%) equal to (i) the greatest of (A) the Prime Rate (as defined in the Restated Credit Facility) in effect on such day, (B) the NYFRB Rate (as defined in the Restated Credit Facility) in effect on such day plus ½ of 1.0%, and (C) the adjusted one-month term SOFR rate plus 1.0% per annum, plus (ii) an applicable margin, which ranges from 0.125% to 1.000%, based on the credit ratings of the Company’s senior unsecured non-credit enhanced long-term indebtedness for borrowed money. The Restated Credit Facility contains certain loan covenants that are customary for credit facilities of this type and that restrict the ability of Concentrix Corporation and its subsidiaries to take certain actions, including the creation of liens, mergers or consolidations, changes to the nature of their business, and, solely with respect to subsidiaries of Concentrix Corporation, incurrence of indebtedness. In addition, the Restated Credit Facility contains financial covenants that require the Company to maintain at the end of each fiscal quarter, (i) a consolidated leverage ratio (as defined in the Restated Credit Facility) not to exceed 3.75 to 1.0 (or for certain periods following certain qualified acquisitions, including the Webhelp Combination, 4.25 to 1.0) and (ii) a consolidated interest coverage ratio (as defined in the Restated Credit Facility) equal to or greater than 3.00 to 1.0. The Restated Credit Facility also contains various customary events of default, including payment defaults, defaults under certain other indebtedness, and a change of control of Concentrix Corporation. None of Concentrix’ subsidiaries guarantees the obligations under the Restated Credit Facility. Prior to entering into the Amendment Agreement, obligations under the Company’s Prior Credit Facility were secured by substantially all of the assets of Concentrix Corporation and certain of its U.S. subsidiaries and were guaranteed by certain of its U.S. subsidiaries. Borrowings under the Prior Credit Facility bore interest, in the case of term or daily SOFR loans, at a per annum rate equal to the applicable SOFR rate (but not less than 0.0%), plus an adjustment of between 0.10% and 0.25% depending on the interest period of each SOFR loan, plus an applicable margin, which ranged from 1.25% to 2.00%, based on the Company’s consolidated leverage ratio. Borrowings under the Prior Credit Facility that were base rate loans bore interest at a per annum rate equal to (i) the greatest of (a) the Federal Funds Rate in effect on such day plus ½ of 1.00%, (b) the rate of interest last publicly announced by Bank of America as its “prime rate” and (c) the term SOFR rate plus 1.00%, plus (ii) an applicable margin, which ranged from 0.25% to 1.00%, based on the Company’s consolidated leverage ratio. From August 31, 2022 through the date of the Amendment Agreement, the outstanding principal of the term loans under the Prior Credit Facility was payable in quarterly installments of $26,250. At February 29, 2024 and November 30, 2023, no amounts were outstanding under the Company’s revolving credit facility. During the three months ended February 28, 2023, the Company voluntarily prepaid $25,000 of the principal balance on the term loans under the Prior Credit Facility, without penalty. Securitization Facility The Company has an amended Securitization Facility that provides for available borrowings of up to $500,000 with a termination date of July 5, 2024. Borrowings under the Securitization Facility that are funded through the issuance of commercial paper bear interest at the applicable commercial paper rate plus a spread of 0.70% and, otherwise, at a per annum rate equal to the applicable SOFR rate (which includes a credit spread adjustment to the SOFR rate of 0.10%), plus a spread of 0.80%. Amounts drawn under the Securitization Facility have been classified as long-term debt within the consolidated balance sheet based on the Company’s ability and intent to refinance on a long-term basis as of February 29, 2024 and November 30, 2023. Under the Securitization Facility, Concentrix Corporation and certain of its subsidiaries (the “Originators”) sell or otherwise transfer all of their accounts receivable to a special purpose bankruptcy-remote subsidiary of the Company (the “Borrower”) that grants a security interest in the receivables to the lenders in exchange for available borrowings of up to $500,000. The amount received under the Securitization Facility is recorded as debt on the Company’s consolidated balance sheets. Borrowing availability under the Securitization Facility may be limited by the Company’s accounts receivable balances, changes in the credit ratings of the clients comprising the receivables, client concentration levels in the receivables, and certain characteristics of the accounts receivable being transferred (including factors tracking performance of the accounts receivable over time). The Securitization Facility contains various affirmative and negative covenants, including a consolidated leverage ratio covenant that is consistent with the Restated Credit Facility and customary events of default, including payment defaults, defaults under certain other indebtedness, a change in control of Concentrix Corporation, and certain events negatively affecting the overall credit quality of the transferred accounts receivable. The Borrower’s sole business consists of the purchase or acceptance through capital contributions of the receivables and related security from the Originators and the subsequent retransfer of or granting of a security interest in such receivables and related security to the administrative agent under the Securitization Facility for the benefit of the lenders. The Borrower is a separate legal entity with its own separate creditors who will be entitled, upon its liquidation, to be satisfied out of the Borrower’s assets prior to any assets or value in the Borrower becoming available to the Borrower’s equity holders, and the assets of the Borrower are not available to pay creditors of the Company and its subsidiaries. Sellers’ Note On September 25, 2023, as part of the consideration for the Webhelp Combination, Concentrix Corporation issued the Sellers’ Note in the aggregate principal amount of €700,000 to certain Sellers. The stated rate of interest associated with the Sellers’ Note is two percent (2.00%) per annum, which is below the Company’s expected borrowing rate. As a result, the Company discounted the Sellers’ Note by €31,500 using an approximate 4.36% imputed annual interest rate. This discounting resulted in an initial value of €668,500 or $711,830. The discounted value is being amortized into interest expense over the two-year term. All stated principal and accrued interest will be due and payable on September 25, 2025. Covenant compliance As of February 29, 2024 and November 30, 2023, Concentrix was in compliance with all covenants for the above arrangements.

EARNINGS PER SHARE

EARNINGS PER SHARE	3 Months Ended
EARNINGS PER SHARE	Feb. 29, 2024
Earnings Per Share [Abstract]
EARNINGS PER SHARE	EARNINGS PER SHARE: Basic and diluted earnings per common share ( “ EPS ” ) are computed using the two-class method, which is an earnings allocation formula that determines EPS for each class of common stock and participating security. Three Months Ended February 29, 2024 February 28, 2023 Basic earnings per common share: Net income $ 52,102 $ 87,870 Less: net income allocated to participating securities (1) (2,002) (1,556) Net income attributable to common stockholders $ 50,100 $ 86,314 Weighted-average number of common shares - basic 65,664 51,150 Basic earnings per common share $ 0.76 $ 1.69 Diluted earnings per common share: Net income $ 52,102 $ 87,870 Less: net income allocated to participating securities (1) (1,998) (1,546) Net income attributable to common stockholders $ 50,104 $ 86,324 Weighted-average number of common shares - basic 65,664 51,150 Effect of dilutive securities: Stock options and restricted stock units 126 326 Weighted-average number of common shares - diluted 65,790 51,476 Diluted earnings per common share $ 0.76 $ 1.68 (1) Restricted stock awards granted to employees by the Company are considered participating securities. Effective in the fourth quarter of fiscal year 2023, restricted stock units granted are also considered participating securities.

REVENUE

REVENUE	3 Months Ended
REVENUE	Feb. 29, 2024
Revenue from Contract with Customer [Abstract]
REVENUE	REVENUE: Disaggregated revenue In the following table, the Company’s revenue is disaggregated by primary industry verticals: Three Months Ended February 29, 2024 February 28, 2023 Industry vertical: Technology and consumer electronics $ 665,102 $ 516,608 Retail, travel and ecommerce 583,712 305,504 Communications and media 380,165 256,987 Banking, financial services and insurance 365,422 259,653 Healthcare 191,089 177,824 Other 217,258 119,828 Total $ 2,402,748 $ 1,636,404

PENSION AND EMPLOYEE BENEFITS P

PENSION AND EMPLOYEE BENEFITS PLANS	3 Months Ended
PENSION AND EMPLOYEE BENEFITS PLANS	Feb. 29, 2024
Retirement Benefits [Abstract]
PENSION AND EMPLOYEE BENEFITS PLANS	PENSION AND EMPLOYEE BENEFITS PLANS: The Company has a 401(k) plan in the United States under which eligible employees may contribute up to the maximum amount as provided by law. Employees become eligible to participate in the 401(k) plan on the first day of the month after their employment date. The Company may make discretionary contributions under the plan. Employees in most of the Company’s non-U.S. legal entities are covered by government mandated defined contribution plans. During the three months ended February 29, 2024 and February 28, 2023, the Company contributed $26,116 and $22,654, respectively, to defined contribution plans. Defined Benefit Plans For eligible employees in the United States, the Company maintains a frozen defined benefit pension plan (“the cash balance plan”), which includes both a qualified and non-qualified portion. The pension benefit formula for the cash balance plan is determined by a combination of compensation, age-based credits, and annual guaranteed interest credits. The qualified portion of the cash balance plan has been funded through contributions made to a trust fund. The Company maintains funded or unfunded defined benefit pension or retirement plans for certain eligible employees in the Philippines, Malaysia, India, and France. Benefits under these plans are primarily based on years of service and compensation during the years immediately preceding retirement or termination of participation in the plans. Net benefit costs related to defined benefit plans were $3,579 and $2,934, during the three months ended February 29, 2024 and February 28, 2023, respectively. On an aggregate basis, the plans were underfunded by $82,491 and $81,813 at February 29, 2024 and November 30, 2023, respectively.

INCOME TAXES

INCOME TAXES	3 Months Ended
INCOME TAXES	Feb. 29, 2024
Income Tax Disclosure [Abstract]
INCOME TAXES	INCOME TAXES: Income taxes consist of current and deferred tax expense resulting from income earned in domestic and international jurisdictions. The effective tax rates for the three months ended February 29, 2024 and February 28, 2023 were impacted by the geographic mix of worldwide income and certain discrete items.

LEASES

LEASES	3 Months Ended
LEASES	Feb. 29, 2024
Leases [Abstract]
LEASES	LEASES: The Company leases certain of its facilities and equipment under operating lease agreements, which expire in various periods through 2037. The Company’s finance leases are not material. The following table presents the various components of operating lease costs: Three Months Ended February 29, 2024 February 28, 2023 Operating lease cost $ 68,920 $ 51,760 Short-term lease cost 20,486 4,719 Variable lease cost 10,756 12,331 Sublease income (492) (1,363) Total operating lease cost $ 99,670 $ 67,447 The following table presents a maturity analysis of expected undiscounted cash flows for operating leases on an annual basis for the next five fiscal years and thereafter as of February 29, 2024: Fiscal Years Ending November 30, 2024 (remaining nine months) $ 219,100 2025 253,922 2026 188,929 2027 130,847 2028 92,334 Thereafter 153,969 Total payments 1,039,101 Less: imputed interest* 156,627 Total present value of lease payments $ 882,474 *Imputed interest represents the difference between undiscounted cash flows and discounted cash flows. The following amounts were recorded in the consolidated balance sheets related to the Company’s operating leases: As of February 29, 2024 November 30, 2023 Operating lease ROU assets Other assets, net $ 839,337 $ 813,590 Current operating lease liabilities Other accrued liabilities 233,019 229,010 Non-current operating lease liabilities Other long-term liabilities 649,455 623,290 The following table presents supplemental cash flow information related to the Company’s operating leases. Cash payments related to variable lease costs and short-term leases are not included in the measurement of operating lease liabilities, and, as such, are excluded from the amounts below: Three Months Ended February 29, 2024 February 28, 2023 Cash paid for amounts included in the measurement of lease liabilities $ 75,842 $ 53,825 Non-cash ROU assets obtained in exchange for lease liabilities 87,511 41,394 The weighted-average remaining lease term and discount rate as of February 29, 2024 and November 30, 2023 were as follows: As of February 29, 2024 November 30, 2023 Weighted-average remaining lease term (years) 4.77 4.88 Weighted-average discount rate 6.52 % 6.41 %

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	3 Months Ended
COMMITMENTS AND CONTINGENCIES	Feb. 29, 2024
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	COMMITMENTS AND CONTINGENCIES: From time to time, the Company receives notices from third parties, including customers and suppliers, seeking indemnification, payment of money, or other actions in connection with claims made against them. Also, from time to time, the Company has been involved in various bankruptcy preference actions where the Company was a supplier to the companies now in bankruptcy. In addition, the Company is subject to various other claims, both asserted and unasserted, that arise in the ordinary course of business. The Company evaluates these claims and records the related liabilities. It is possible that the liabilities ultimately incurred by the Company could differ from the amounts recorded.

STOCKHOLDERS' EQUITY

STOCKHOLDERS' EQUITY	3 Months Ended
STOCKHOLDERS' EQUITY	Feb. 29, 2024
Equity [Abstract]
STOCKHOLDERS' EQUITY	NOTE 15—STOCKHOLDERS’ EQUITY: Share repurchase program In September 2021, the Company’s board of directors authorized the Company to purchase up to $500,000 of the Company’s outstanding shares of common stock from time to time as market and business conditions warrant, including through open market purchases or Rule 10b5-1 trading plans. The repurchase program has no termination date and may be suspended or discontinued at any time. During the three months ended February 29, 2024 and February 28, 2023, the Company repurchased 237 and 71 shares, respectively, of its common stock for an aggregate purchase price of $21,674 and $10,001, respectively. The share repurchases were made on the open market and the shares repurchased by the Company are held in treasury for general corporate purposes. At February 29, 2024, approximately $268,452 remained available for share repurchases under the existing authorization from the Company’s board of directors. During March 2023, the Company repurchased 184 shares of its common stock for an aggregate purchase price of $11,964. Dividends During fiscal years 2024 and 2023, the Company has paid the following dividends per share approved by the Company’s board of directors: Announcement Date Record Date Per Share Dividend Amount Payment Date January 19, 2023 January 30, 2023 $0.275 February 10, 2023 March 29, 2023 April 28, 2023 $0.275 May 9, 2023 June 28, 2023 July 28, 2023 $0.275 August 8, 2023 September 27, 2023 October 27, 2023 $0.3025 November 7, 2023 January 24, 2024 February 5, 2024 $0.3025 February 15, 2024 On March 26, 2024, the Company announced a cash dividend of $0.3025 per share to stockholders of record as of April 26, 2024, payable on May 7, 2024.

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Thousands	3 Months Ended
Pay vs Performance Disclosure - USD ($) $ in Thousands	Feb. 29, 2024	Feb. 28, 2023
Pay vs Performance Disclosure
Net Income (Loss)	$ 52,102	$ 87,870

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
Insider Trading Arrangements	Feb. 29, 2024 shares
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	true
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false
Cormac Twomey [Member]
Trading Arrangements, by Individual
Material Terms of Trading Arrangement	Name and Title Action Taken (Date of Action) Type of Trading Arrangement Nature of Trading Arrangement Aggregate Number of Securities to be Purchased or Sold Duration of Trading Arrangement Cormac Twomey Executive Vice President, Customer Success Adoption (January 29, 2024) Rule 10b5-1 trading arrangement Sales Up to 6,544 shares of common stock (1) April 4, 2025 (2) (1) Represents the aggregate number of securities designated for sale under the 10b5-1 trading arrangement prior to the reduction of shares related to tax withholding upon vesting of certain individual’s equity awards. (2) This trading arrangement terminates on the earlier of (a) the execution or expiration of all trades or trading orders, (b) notice of termination, or (c) the date listed in the table.
Name	Cormac Twomey
Title	Executive Vice President, Customer Success
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	January 29, 2024
Arrangement Duration	431 days
Aggregate Available	6,544

Organization, Consolidation and

Organization, Consolidation and Presentation of Financial Statements (Policies)	3 Months Ended
	Feb. 29, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Reclassifications	Reclassifications Certain amounts in the consolidated financial statements related to the prior years have been reclassified to conform to the current year’s presentation.

SUMMARY OF SIGNIFICANT ACCOUN_2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	3 Months Ended
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	Feb. 29, 2024
Accounting Policies [Abstract]
Basis of presentation	Basis of presentation The accompanying interim unaudited consolidated financial statements have been prepared by the Company in accordance with the rules and regulations of the Securities and Exchange Commission (“SEC”). The amounts as of November 30, 2023 have been derived from the Company’s annual audited financial statements included in the Company’s Annual Report on Form 10-K for the fiscal year ended November 30, 2023. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles (“GAAP”) in the United States have been condensed or omitted in accordance with such rules and regulations. In the opinion of management, the accompanying unaudited consolidated financial statements reflect all adjustments, consisting only of normal recurring adjustments, necessary to state fairly the financial position of the Company and its results of operations and cash flows as of and for the periods presented. These interim consolidated financial statements should be read in conjunction with the annual audited financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended November 30, 2023. All intercompany balances and transactions have been eliminated in consolidation.
Concentration of credit risk	Concentration of credit risk For the three months ended February 29, 2024 and February 28, 2023, no client accounted for more than 10% of the Company’s consolidated revenue.
Recently adopted accounting pronouncements and Recently issued accounting pronouncements	Recently adopted accounting pronouncements In November 2023, the Financial Accounting Standards Board (the “FASB”) issued accounting standards update (“ASU”) 2023-07, which enhances the disclosures required for reportable segments in annual and interim consolidated financial statements. ASU 2023-07 is effective for the Company for annual reporting periods beginning with the fiscal year ending November 30, 2025 and for interim reporting periods beginning in fiscal year 2026. Early adoption is permitted. The Company is currently evaluating the impact that this update will have on its disclosures in the consolidated financial statements. In December 2023, the FASB issued ASU 2023-09, which requires enhanced income tax disclosures, including disaggregation of information in the rate reconciliation table and disaggregated information related to income taxes paid. The amendments in ASU 2023-09 are effective for the fiscal year ending November 30, 2026. The Company is currently evaluating the impact that this update will have on its disclosures in the consolidated financial statements.

ACQUISITION (Tables)

ACQUISITION (Tables)	3 Months Ended
ACQUISITION (Tables)	Feb. 29, 2024
Business Combination and Asset Acquisition [Abstract]
Schedule of Business Acquisitions by Acquisition, Contingent Consideration	The preliminary purchase price consideration to acquire Webhelp consisted of the following: Cash consideration for Shares (1) $ 529,160 Cash consideration for repayment of Webhelp debt and shareholder loan (2) 1,915,197 Total cash consideration 2,444,357 Equity consideration (3) 1,084,894 Earnout shares contingent consideration (4) 32,919 Sellers’ note consideration (5) 711,830 Total consideration transferred 4,274,000 Less: Cash and restricted cash acquired (6) 499,211 Total purchase price consideration $ 3,774,789 (1) Represents the cash consideration paid, and to be paid, in the aggregate amount of €500,000, as adjusted in accordance with the SPA. (2) Represents the cash consideration paid to repay Webhelp’s outstanding senior loan debt and shareholder loan. (3) Represents the issuance of 14,862 shares of common stock, par value $0.0001 per share, of Concentrix Corporation (the “Concentrix common stock”). (4) Represents the contingent right for the Sellers to earn an additional 750 shares of Concentrix common stock (the “Earnout Shares”). The estimated fair value of this contingent consideration was determined using a Monte-Carlo simulation model. The inputs include the closing price of Concentrix common stock as of the Closing Date, Concentrix-specific historical equity volatility, and the risk-free rate. See further details below. (5) Represents a promissory note issued by Concentrix Corporation in the aggregate principal amount of €700,000 to certain Sellers. See Note 8 — Borrowings for a further discussion of this promissory note. (6)
Schedule of Business Acquisitions	The following table summarizes the preliminary fair values of the assets acquired and liabilities assumed as of the acquisition date: As of September 25, 2023 Assets acquired: Cash and cash equivalents $ 310,313 Accounts receivable 455,218 Other current assets (1) 454,465 Property and equipment 323,606 Identifiable intangible assets 1,984,000 Goodwill 2,098,531 Deferred tax assets 22,541 Other assets 410,085 6,058,759 Liabilities assumed: Accounts payable 67,558 Accrued compensation and benefits 246,450 Other accrued liabilities 576,549 Income taxes payable 72,227 Debt (current portion and long-term) 8,589 Deferred tax liabilities 411,788 Other long-term liabilities 401,598 Total liabilities assumed 1,784,759 Total consideration transferred $ 4,274,000 (1) Includes restricted cash acquired of $188,899.
Schedule of Acquired Finite-Lived Intangible Assets by Major Class	The preliminary amounts allocated to intangible assets are as follows: Gross Carrying Amount Weighted-Average Useful Life Amortization Method Customer relationships $ 1,882,000 15 years Accelerated Trade name 102,000 3 years Straight-line Total $ 1,984,000
Business Acquisition, Pro Forma Information	The supplemental pro forma financial information for the prior period first fiscal quarter ended February 28, 2023 is as follows: Three Months Ended February 28, 2023 Revenue $ 2,362,015 Net income 17,482

SHARE-BASED COMPENSATION (Table

SHARE-BASED COMPENSATION (Tables)	3 Months Ended
SHARE-BASED COMPENSATION (Tables)	Feb. 29, 2024
Share-Based Payment Arrangement [Abstract]
Schedule of Share-based Compensation Expense	The Company recorded share-based compensation expense in the consolidated statements of operations for the three months ended February 29, 2024 and February 28, 2023 as follows: Three Months Ended February 29, 2024 February 28, 2023 Total share-based compensation $ 21,646 $ 16,754 Tax benefit recorded in the provision for income taxes (5,411) (4,188) Effect on net income $ 16,235 $ 12,566

BALANCE SHEET COMPONENTS (Table

BALANCE SHEET COMPONENTS (Tables)	3 Months Ended
BALANCE SHEET COMPONENTS (Tables)	Feb. 29, 2024
Balance Sheet Related Disclosures [Abstract]
Schedule of Cash and Cash Equivalents	The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the consolidated balance sheets that sum to the total of the same amounts shown in the consolidated statements of cash flows: As of February 29, 2024 November 30, 2023 Cash and cash equivalents $ 234,794 $ 295,336 Restricted cash included in other current assets 183,161 221,151 Cash, cash equivalents and restricted cash $ 417,955 $ 516,487
Schedule of Restricted Cash and Cash Equivalents	The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the consolidated balance sheets that sum to the total of the same amounts shown in the consolidated statements of cash flows: As of February 29, 2024 November 30, 2023 Cash and cash equivalents $ 234,794 $ 295,336 Restricted cash included in other current assets 183,161 221,151 Cash, cash equivalents and restricted cash $ 417,955 $ 516,487
Schedule of Accounts Receivable	Accounts receivable, net is comprised of the following as of February 29, 2024 and November 30, 2023: As of February 29, 2024 November 30, 2023 Billed accounts receivable $ 1,098,480 $ 1,082,469 Unbilled accounts receivable 840,339 818,954 Less: Allowance for doubtful accounts (11,175) (12,533) Accounts receivable, net $ 1,927,644 $ 1,888,890
Schedule of Allowance for Doubtful Trade Receivables	Presented below is a progression of the allowance for doubtful trade receivables: Three Months Ended February 29, 2024 February 28, 2023 Balance at beginning of period $ 12,533 $ 4,797 Net additions (reductions) (180) 1,722 Write-offs and reclassifications (1,178) (435) Balance at end of period $ 11,175 $ 6,084
Property, Plant and Equipment	The following table summarizes the carrying amounts and related accumulated depreciation for property and equipment as of February 29, 2024 and November 30, 2023: As of February 29, 2024 November 30, 2023 Land $ 28,276 $ 28,039 Equipment, computers and software 777,778 762,961 Furniture and fixtures 157,760 157,425 Buildings, building improvements and leasehold improvements 567,571 566,384 Construction-in-progress 35,869 35,175 Total property and equipment, gross $ 1,567,254 $ 1,549,984 Less: Accumulated depreciation (837,012) (801,293) Property and equipment, net $ 730,242 $ 748,691 Shown below are the countries where 10% or more and other significant concentrations of the Company’s property and equipment, net are located as of February 29, 2024 and November 30, 2023: As of February 29, 2024 November 30, 2023 Property and equipment, net: United States $ 121,875 $ 123,335 Philippines 72,460 75,943 France 70,913 65,599 India 48,895 51,248 Others 416,099 432,566 Total $ 730,242 $ 748,691
Schedule of Goodwill	The following table summarizes the changes in the Company’s goodwill for the three months ended February 29, 2024 and February 28, 2023: Three Months Ended February 29, 2024 February 28, 2023 Balance at beginning of period $ 5,078,668 $ 2,904,402 Acquisition measurement period adjustments 13,187 — Foreign exchange translation (61,199) 676 Balance at end of period $ 5,030,656 $ 2,905,078
Schedule of Intangible Assets	The following tables summarize the carrying amounts and related accumulated amortization for intangible assets as of February 29, 2024 and November 30, 2023: As of February 29, 2024 As of November 30, 2023 Gross amounts Accumulated amortization Net amounts Gross amounts Accumulated amortization Net amounts Customer relationships $ 3,652,193 $ (1,111,685) $ 2,540,508 $ 3,670,246 $ (1,011,201) $ 2,659,045 Technology 79,690 (39,642) 40,048 79,739 (36,174) 43,565 Trade names 117,948 (26,471) 91,477 118,823 (17,255) 101,568 Non-compete agreements 2,200 (1,597) 603 2,200 (1,413) 787 $ 3,852,031 $ (1,179,395) $ 2,672,636 $ 3,871,008 $ (1,066,043) $ 2,804,965
Schedule of Intangible Assets, Future Amortization Expense	Estimated future amortization expense of the Company’s intangible assets is as follows: Fiscal years ending November 30, 2024 (remaining nine months) $ 344,518 2025 428,418 2026 381,018 2027 288,145 2028 244,272 Thereafter 986,265 Total $ 2,672,636
Schedule of Accumulated Other Comprehensive Income (Loss)	The components of accumulated other comprehensive income (loss) (“AOCI”), net of taxes, were as follows: Three Months Ended February 29, 2024 and February 28, 2023 Unrecognized gains (losses) on defined benefit plan, net of taxes Unrealized gains (losses) on hedges, net of taxes Foreign currency translation adjustments, net of taxes Total Balances at November 30, 2022 $ (8,471) $ (19,914) $ (287,364) $ (315,749) Other comprehensive income (loss) before reclassification (552) 7,654 17,243 24,345 Reclassification of losses from other comprehensive income (loss) — 5,807 — 5,807 Balances at February 28, 2023 $ (9,023) $ (6,453) $ (270,121) $ (285,597) Balances at November 30, 2023 $ (11,271) $ 4,489 $ (184,945) $ (191,727) Other comprehensive income (loss) before reclassification 1,304 (4,020) (69,412) (72,128) Reclassification of gains from other comprehensive income (loss) — (427) — (427) Balances at February 29, 2024 $ (9,967) $ 42 $ (254,357) $ (264,282)

DERIVATIVE INSTRUMENTS (Tables)

DERIVATIVE INSTRUMENTS (Tables)	3 Months Ended
DERIVATIVE INSTRUMENTS (Tables)	Feb. 29, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Derivative Instruments in Statement of Financial Position, Fair Value	The fair values of the Company’s derivative instruments are disclosed in Note 7—Fair Value Measurements and summarized in the table below: Value as of Balance Sheet Line Item February 29, 2024 November 30, 2023 Derivative instruments not designated as hedging instruments: Foreign exchange forward contracts (notional value) $ 1,478,401 $ 2,173,330 Other current assets 10,519 16,078 Other accrued liabilities 9,556 20,856 Derivative instruments designated as fair value hedges: Cross-currency interest rate swaps (notional value) $ 471,604 $ 471,604 Other long-term liabilities 12,988 17,219 Derivative instruments designated as cash flow hedges: Foreign exchange forward contracts (notional value) $ 1,013,034 $ 996,667 Other current assets and other assets 9,849 14,330 Other accrued liabilities and other long-term liabilities 4,244 2,724
Derivative Instruments, Gain (Loss)	The following table shows the gains and losses, before taxes, of the Company’s derivative instruments designated as cash flow hedges and not designated as hedging instruments in other comprehensive income (“OCI”), and the consolidated statements of operations for the periods presented: Three Months Ended Locations of gain (loss) in statement of operations February 29, 2024 February 28, 2023 Derivative instruments designated as cash flow and fair value hedges: Gains (losses) recognized in OCI: Foreign exchange forward contracts $ (5,423) $ 10,203 Cross-currency interest rate swaps 75 — Total $ (5,348) $ 10,203 Gains (losses) reclassified from AOCI into income: Foreign exchange forward contracts Gain (loss) reclassified from AOCI into income Cost of revenue for services $ 454 $ (5,760) Gain (loss) reclassified from AOCI into income Selling, general and administrative expenses 123 (1,981) Total $ 577 $ (7,741) Derivative instruments not designated as hedging instruments: Gain recognized from foreign exchange forward contracts, net (1) Other expense (income), net $ 337 $ 6,225 (1)

FAIR VALUE MEASUREMENTS (Tables

FAIR VALUE MEASUREMENTS (Tables)	3 Months Ended
FAIR VALUE MEASUREMENTS (Tables)	Feb. 29, 2024
Fair Value Disclosures [Abstract]
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis	The following table summarizes the valuation of the Company’s investments and financial instruments that are measured at fair value on a recurring basis: As of February 29, 2024 As of November 30, 2023 Fair value measurement category Fair value measurement category Total Level 1 Level 2 Level 3 Total Level 1 Level 2 Level 3 Assets measured at fair value: Cash equivalents $ 49,236 $ 49,236 $ — $ — $ 52,847 $ 52,847 $ — $ — Foreign government bond — — — — 1,853 1,853 — — Forward foreign currency exchange contracts 20,368 — 20,368 — 30,408 — 30,408 — Liabilities measured at fair value: Forward foreign currency exchange contracts 13,800 — 13,800 — 23,580 — 23,580 — Cross-currency interest rate swaps 12,988 — 12,988 — 17,219 — 17,219 — Acquisition contingent consideration 31,940 — 31,940 — 48,600 — 48,600 — Liabilities measured at other than fair value: Long term debt (senior notes) Fair value 2,149,981 — 2,149,981 — 2,146,554 — 2,146,554 — Carrying amount 2,132,774 — — — 2,131,870 — — —

BORROWINGS (Tables)

BORROWINGS (Tables)	3 Months Ended
BORROWINGS (Tables)	Feb. 29, 2024
Debt Disclosure [Abstract]
Schedule of Debt	Borrowings consist of the following: As of February 29, 2024 November 30, 2023 Other loans $ 2,714 $ 2,313 Current portion of long-term debt $ 2,714 $ 2,313 6.650% Senior Notes due 2026 $ 800,000 $ 800,000 6.600% Senior Notes due 2028 800,000 800,000 6.850% Senior Notes due 2033 550,000 550,000 Credit Facility - Term Loan component 1,850,000 1,950,000 Securitization Facility 326,000 128,500 Sellers’ Note 756,177 762,286 Other loans 2,509 5,301 Long-term debt, before unamortized debt discount and issuance costs 5,084,686 4,996,087 Less: unamortized debt discount and issuance costs (50,577) (56,375) Long-term debt, net $ 5,034,109 $ 4,939,712

EARNINGS PER SHARE (Tables)

EARNINGS PER SHARE (Tables)	3 Months Ended
EARNINGS PER SHARE (Tables)	Feb. 29, 2024
Earnings Per Share [Abstract]
Schedule of Earnings Per Share	Three Months Ended February 29, 2024 February 28, 2023 Basic earnings per common share: Net income $ 52,102 $ 87,870 Less: net income allocated to participating securities (1) (2,002) (1,556) Net income attributable to common stockholders $ 50,100 $ 86,314 Weighted-average number of common shares - basic 65,664 51,150 Basic earnings per common share $ 0.76 $ 1.69 Diluted earnings per common share: Net income $ 52,102 $ 87,870 Less: net income allocated to participating securities (1) (1,998) (1,546) Net income attributable to common stockholders $ 50,104 $ 86,324 Weighted-average number of common shares - basic 65,664 51,150 Effect of dilutive securities: Stock options and restricted stock units 126 326 Weighted-average number of common shares - diluted 65,790 51,476 Diluted earnings per common share $ 0.76 $ 1.68 (1) Restricted stock awards granted to employees by the Company are considered participating securities. Effective in the fourth quarter of fiscal year 2023, restricted stock units granted are also considered participating securities.

REVENUE (Tables)

REVENUE (Tables)	3 Months Ended
REVENUE (Tables)	Feb. 29, 2024
Revenue from Contract with Customer [Abstract]
Disaggregation of Revenue	In the following table, the Company’s revenue is disaggregated by primary industry verticals: Three Months Ended February 29, 2024 February 28, 2023 Industry vertical: Technology and consumer electronics $ 665,102 $ 516,608 Retail, travel and ecommerce 583,712 305,504 Communications and media 380,165 256,987 Banking, financial services and insurance 365,422 259,653 Healthcare 191,089 177,824 Other 217,258 119,828 Total $ 2,402,748 $ 1,636,404

LEASES (Tables)

LEASES (Tables)	3 Months Ended
LEASES (Tables)	Feb. 29, 2024
Leases [Abstract]
Schedule of Lease Cost	The following table presents the various components of operating lease costs: Three Months Ended February 29, 2024 February 28, 2023 Operating lease cost $ 68,920 $ 51,760 Short-term lease cost 20,486 4,719 Variable lease cost 10,756 12,331 Sublease income (492) (1,363) Total operating lease cost $ 99,670 $ 67,447 The weighted-average remaining lease term and discount rate as of February 29, 2024 and November 30, 2023 were as follows: As of February 29, 2024 November 30, 2023 Weighted-average remaining lease term (years) 4.77 4.88 Weighted-average discount rate 6.52 % 6.41 %
Operating Lease Liability Maturity Schedule	The following table presents a maturity analysis of expected undiscounted cash flows for operating leases on an annual basis for the next five fiscal years and thereafter as of February 29, 2024: Fiscal Years Ending November 30, 2024 (remaining nine months) $ 219,100 2025 253,922 2026 188,929 2027 130,847 2028 92,334 Thereafter 153,969 Total payments 1,039,101 Less: imputed interest* 156,627 Total present value of lease payments $ 882,474
Schedule of Amounts Recorded In Consolidated Balance Sheet Related to Operating Leases	The following amounts were recorded in the consolidated balance sheets related to the Company’s operating leases: As of February 29, 2024 November 30, 2023 Operating lease ROU assets Other assets, net $ 839,337 $ 813,590 Current operating lease liabilities Other accrued liabilities 233,019 229,010 Non-current operating lease liabilities Other long-term liabilities 649,455 623,290
Schedule of Supplemental Cash Flow Information Related to Operating Leases	The following table presents supplemental cash flow information related to the Company’s operating leases. Cash payments related to variable lease costs and short-term leases are not included in the measurement of operating lease liabilities, and, as such, are excluded from the amounts below: Three Months Ended February 29, 2024 February 28, 2023 Cash paid for amounts included in the measurement of lease liabilities $ 75,842 $ 53,825 Non-cash ROU assets obtained in exchange for lease liabilities 87,511 41,394

STOCKHOLDERS' EQUITY (Tables)

STOCKHOLDERS' EQUITY (Tables)	3 Months Ended
STOCKHOLDERS' EQUITY (Tables)	Feb. 29, 2024
Equity [Abstract]
Dividends Declared	During fiscal years 2024 and 2023, the Company has paid the following dividends per share approved by the Company’s board of directors: Announcement Date Record Date Per Share Dividend Amount Payment Date January 19, 2023 January 30, 2023 $0.275 February 10, 2023 March 29, 2023 April 28, 2023 $0.275 May 9, 2023 June 28, 2023 July 28, 2023 $0.275 August 8, 2023 September 27, 2023 October 27, 2023 $0.3025 November 7, 2023 January 24, 2024 February 5, 2024 $0.3025 February 15, 2024 On March 26, 2024, the Company announced a cash dividend of $0.3025 per share to stockholders of record as of April 26, 2024, payable on May 7, 2024.

BACKGROUND AND BASIS OF PRESE_2

BACKGROUND AND BASIS OF PRESENTATION (Details)	Feb. 29, 2024 market
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Primary industry verticals	5

ACQUISITIONS - Narrative (Detai

ACQUISITIONS - Narrative (Details) - USD ($) $ / shares in Units, $ in Thousands		3 Months Ended
	Sep. 25, 2023	Feb. 29, 2024	Feb. 28, 2023	Nov. 30, 2023	Aug. 02, 2023
Business Acquisition [Line Items]
Acquisition of business, net of cash and restricted cash acquired		$ 4,503	$ 0
Acquisition-related and integration expenses		$ 30,173	$ 5,543
Common stock, par value (in dollars per share)		$ 0.0001		$ 0.0001
Common stock, shares outstanding (in shares)		65,572,000		65,734,000
2026 Notes
Business Acquisition [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	6.65%	6.65%			6.65%
Webhelp
Business Acquisition [Line Items]
Acquisition of business, net of cash and restricted cash acquired	$ 3,774,789
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles	1,984,000
Business Acquisition, Note Payable Consideration	$ 700,000
Debt Instrument, Interest Rate, Stated Percentage	2%
Business Acquisition, Right to Receive Equity Interest Issued or Issuable, Minimum Share Price	$ 170
Common stock, par value (in dollars per share)	$ 0.0001
Purchase price	$ 4,274,000
Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures	80,000

ACQUISITIONS - Consideration (D

ACQUISITIONS - Consideration (Details) $ / shares in Units, $ in Thousands, € in Millions			3 Months Ended
	Sep. 25, 2023 USD ($) $ / shares shares	Sep. 25, 2023 EUR (€) shares	Feb. 29, 2024 USD ($) $ / shares shares	Feb. 28, 2023 USD ($)	Nov. 30, 2023 $ / shares shares
Business Acquisition [Line Items]
Acquisition-related and integration expenses			$ 30,173	$ 5,543
Acquisition of business, net of cash and restricted cash acquired			$ 4,503	$ 0
Common stock, shares issued (in shares) \| shares	14,862,000		67,981,000		67,883,000
Common stock, par value (in dollars per share) \| $ / shares			$ 0.0001		$ 0.0001
Webhelp
Business Acquisition [Line Items]
Payments to Acquire Businesses, Gross, Cash Consideration for Stock	$ 529,160	€ 500
Payments to Acquire Businesses, Gross, Cash Consideration for Repayment of Debt, Including Accrued Interest	1,915,197
Business Combination, Consideration Transferred, Other	1,084,894
Purchase price	4,274,000
Cash Acquired from Acquisition	499,211
Acquisition of business, net of cash and restricted cash acquired	$ 3,774,789
Common stock, par value (in dollars per share) \| $ / shares	$ 0.0001
Business Combination, Consideration Transferred, Liabilities Incurred	$ 711,830	€ 700
Business Acquisition, Right to Receive Equity Interest Issued or Issuable, Minimum Share Price \| $ / shares	$ 170
Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures \| shares	80,000	80,000
Business Acquisition, Right to Receive Equity Interest Issued or Issuable, Number of Shares \| shares	750,000	750,000

ACQUISITIONS - Purchase Price (

ACQUISITIONS - Purchase Price (Details) € in Millions			3 Months Ended
ACQUISITIONS - Purchase Price (Details) € in Millions	Sep. 25, 2023 USD ($)	Sep. 25, 2023 EUR (€)	Feb. 29, 2024 USD ($)	Feb. 28, 2023 USD ($)	Nov. 30, 2023 USD ($)	Nov. 30, 2022 USD ($)
Business Acquisition [Line Items]
Goodwill			$ 5,030,656,000	$ 2,905,078,000	$ 5,078,668,000	$ 2,904,402,000
Acquisition of business, net of cash and restricted cash acquired			$ 4,503,000	$ 0
Webhelp
Business Acquisition [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents	$ 310,313,000
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables	455,218,000
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment	323,606,000
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles	1,984,000,000
Goodwill	2,098,531,000
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets	410,085,000
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets	6,058,759,000
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable	67,558,000
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities	411,788,000
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities	1,784,759,000
Purchase price	4,274,000,000
Acquisition of business, net of cash and restricted cash acquired	3,774,789,000
Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets	22,541,000
Payments to Acquire Businesses, Gross, Cash Consideration for Stock	529,160,000	€ 500
Payments to Acquire Businesses, Gross, Cash Consideration for Repayment of Debt, Including Accrued Interest	1,915,197,000
Payments to Acquire Business, Gross, Including Cash Consideration for Stock and Repayment of Debt	2,444,357,000
Business Combination, Consideration Transferred, Other	1,084,894,000
Business Combination, Consideration Transferred, Equity Interests Issued and Issuable	32,919,000
Business Combination, Consideration Transferred, Liabilities Incurred	711,830,000	€ 700
Cash Acquired from Acquisition	499,211,000
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other	454,465,000
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accrued Compensation and Benefits	246,450,000
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other	576,549,000
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Income Taxes Payable	72,227,000
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Long-Term Debt	8,589,000
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other	401,598,000
Restricted Cash	$ 188,899,000

ACQUISITIONS - Intangible Asset

ACQUISITIONS - Intangible Assets (Details) - Webhelp $ in Thousands	Sep. 25, 2023 USD ($)
Business Acquisition [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles	$ 1,984,000
Customer relationships
Business Acquisition [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles	$ 1,882,000
Finite-Lived Intangible Asset, Useful Life	15 years
Trade names
Business Acquisition [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles	$ 102,000
Finite-Lived Intangible Asset, Useful Life	3 years

ACQUISITIONS - Pro Forma (Detai

ACQUISITIONS - Pro Forma (Details) - Webhelp $ in Thousands	3 Months Ended
ACQUISITIONS - Pro Forma (Details) - Webhelp $ in Thousands	Feb. 28, 2023 USD ($)
Business Acquisition [Line Items]
Business Acquisition, Pro Forma Revenue	$ 2,362,015
Business Acquisition, Pro Forma Net Income (Loss)	$ 17,482

SHARE-BASED COMPENSATION - Narr

SHARE-BASED COMPENSATION - Narrative (Details) shares in Thousands	1 Months Ended
	Jan. 31, 2024 $ / shares shares
Restricted Stock Awards and Restricted Stock Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock granted (in shares) \| shares	96
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value \| $ / shares	$ 89.28
Performance-based Restricted Stock Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock granted (in shares) \| shares	115
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value \| $ / shares	$ 85.71
Restricted Stock Awards, Restricted Stock Units and Performance-Based Restricted Stock Units \| Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period	3 years

SHARE-BASED COMPENSATION - Shar

SHARE-BASED COMPENSATION - Share-based Compensation Expense (Details) - USD ($) $ in Thousands	3 Months Ended
	Feb. 29, 2024	Feb. 28, 2023
Share-Based Payment Arrangement [Abstract]
Total share-based compensation	$ 21,646	$ 16,754
Tax benefit recorded in the provision for income taxes	(5,411)	(4,188)
Effect on net income	$ 16,235	$ 12,566

BALANCE SHEET COMPONENTS - Cash

BALANCE SHEET COMPONENTS - Cash, Cash Equivalents and Restricted Cash (Details) - USD ($) $ in Thousands	Feb. 29, 2024	Nov. 30, 2023	Feb. 28, 2023	Nov. 30, 2022
Cash and Cash Equivalents [Line Items]
Cash and cash equivalents	$ 234,794	$ 295,336
Restricted cash included in other current assets	183,161	221,151
Cash, cash equivalents and restricted cash	417,955	516,487	$ 190,030	$ 157,463
Funds Held for Clients	$ 174,303	$ 218,228

BALANCE SHEET COMPONENTS - Acco

BALANCE SHEET COMPONENTS - Accounts Receivable, Net (Details) - USD ($) $ in Thousands	Feb. 29, 2024	Nov. 30, 2023	Feb. 28, 2023	Nov. 30, 2022
Accounts, Notes, Loans and Financing Receivable [Line Items]
Less: Allowance for doubtful accounts	$ (11,175)	$ (12,533)	$ (6,084)	$ (4,797)
Accounts receivable, net	1,927,644	1,888,890
Billed accounts receivable
Accounts, Notes, Loans and Financing Receivable [Line Items]
Accounts receivable, gross	1,098,480	1,082,469
Unbilled accounts receivable
Accounts, Notes, Loans and Financing Receivable [Line Items]
Accounts receivable, gross	$ 840,339	$ 818,954

BALANCE SHEET COMPONENTS - Allo

BALANCE SHEET COMPONENTS - Allowance for Doubtful Trade Receivables (Details) - USD ($) $ in Thousands	3 Months Ended
	Feb. 29, 2024	Feb. 28, 2023	Nov. 30, 2023	Nov. 30, 2022
Accounts Receivable, Allowance for Credit Loss [Roll Forward]
Accounts Receivable, Allowance for Credit Loss, Current	$ 11,175	$ 6,084	$ 12,533	$ 4,797
Write-offs and reclassifications	(1,178)	(435)
Provision for doubtful accounts	$ (180)	$ 1,722

BALANCE SHEET COMPONENTS - Prop

BALANCE SHEET COMPONENTS - Property and Equipment, Net (Details) - USD ($) $ in Thousands	Feb. 29, 2024	Nov. 30, 2023
Property, Plant and Equipment [Line Items]
Total property and equipment, gross	$ 1,567,254	$ 1,549,984
Less: Accumulated depreciation	(837,012)	(801,293)
Property and equipment, net	730,242	748,691
United States
Property, Plant and Equipment [Line Items]
Property and equipment, net	121,875	123,335
Philippines
Property, Plant and Equipment [Line Items]
Property and equipment, net	72,460	75,943
India
Property, Plant and Equipment [Line Items]
Property and equipment, net	48,895	51,248
Other
Property, Plant and Equipment [Line Items]
Property and equipment, net	416,099	432,566
FRANCE
Property, Plant and Equipment [Line Items]
Property and equipment, net	70,913	65,599
Land
Property, Plant and Equipment [Line Items]
Total property and equipment, gross	28,276	28,039
Equipment, computers and software
Property, Plant and Equipment [Line Items]
Total property and equipment, gross	777,778	762,961
Furniture and fixtures
Property, Plant and Equipment [Line Items]
Total property and equipment, gross	157,760	157,425
Buildings, building improvements and leasehold improvements
Property, Plant and Equipment [Line Items]
Total property and equipment, gross	567,571	566,384
Construction-in-progress
Property, Plant and Equipment [Line Items]
Total property and equipment, gross	$ 35,869	$ 35,175

BALANCE SHEET COMPONENTS - Good

BALANCE SHEET COMPONENTS - Goodwill (Details) - USD ($) $ in Thousands	3 Months Ended
	Feb. 29, 2024	Feb. 28, 2023
Goodwill [Roll Forward]
Goodwill, Beginning Balance	$ 5,078,668	$ 2,904,402
Goodwill, Purchase Accounting Adjustments	13,187	0
Foreign exchange translation	(61,199)	676
Goodwill, Ending Balance	$ 5,030,656	$ 2,905,078

BALANCE SHEET COMPONENTS - Inta

BALANCE SHEET COMPONENTS - Intangible Assets, Net (Details) - USD ($) $ in Thousands	Feb. 29, 2024	Nov. 30, 2023
Finite-Lived Intangible Assets [Line Items]
Gross amounts	$ 3,852,031	$ 3,871,008
Accumulated amortization	(1,179,395)	(1,066,043)
Total	2,672,636	2,804,965
Customer relationships
Finite-Lived Intangible Assets [Line Items]
Gross amounts	3,652,193	3,670,246
Accumulated amortization	(1,111,685)	(1,011,201)
Total	2,540,508	2,659,045
Technology
Finite-Lived Intangible Assets [Line Items]
Gross amounts	79,690	79,739
Accumulated amortization	(39,642)	(36,174)
Total	40,048	43,565
Trade names
Finite-Lived Intangible Assets [Line Items]
Gross amounts	117,948	118,823
Accumulated amortization	(26,471)	(17,255)
Total	91,477	101,568
Noncompete Agreements
Finite-Lived Intangible Assets [Line Items]
Gross amounts	2,200	2,200
Accumulated amortization	(1,597)	(1,413)
Total	$ 603	$ 787

BALANCE SHEET COMPONENTS - Esti

BALANCE SHEET COMPONENTS - Estimated Future Amortization Expense (Details) - USD ($) $ in Thousands	Feb. 29, 2024	Nov. 30, 2023
Balance Sheet Related Disclosures [Abstract]
2021 (remaining three months)	$ 344,518
2025	428,418
2026	381,018
2027	288,145
2028	244,272
Thereafter	986,265
Total	$ 2,672,636	$ 2,804,965

BALANCE SHEET COMPONENTS - Accu

BALANCE SHEET COMPONENTS - Accumulated Other Comprehensive Income (Loss) (Details) - USD ($) $ in Thousands	3 Months Ended
	Feb. 29, 2024	Feb. 28, 2023	Nov. 30, 2023	Nov. 30, 2022
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax	$ (427)	$ 5,807
Total stockholders’ equity	4,101,637	2,800,501	$ 4,143,294	$ 2,695,904
Other Comprehensive Income (Loss), before Reclassifications, Net of Tax	(72,128)	24,345
Accumulated Foreign Currency Adjustment Attributable to Parent [Member]
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax	0	0
Total stockholders’ equity	(254,357)	(270,121)	(184,945)	(287,364)
Other Comprehensive Income (Loss), before Reclassifications, Net of Tax	(69,412)	17,243
Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member]
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax	(427)	5,807
Total stockholders’ equity	42	(6,453)	4,489	(19,914)
Other Comprehensive Income (Loss), before Reclassifications, Net of Tax	(4,020)	7,654
Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax	0	0
Total stockholders’ equity	(9,967)	(9,023)	(11,271)	(8,471)
Other Comprehensive Income (Loss), before Reclassifications, Net of Tax	1,304	(552)
Accumulated other comprehensive income (loss)
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Total stockholders’ equity	$ (264,282)	$ (285,597)	$ (191,727)	$ (315,749)

DERIVATIVE INSTRUMENTS - Fair V

DERIVATIVE INSTRUMENTS - Fair Value of Derivative Instruments in Balance Sheets (Details) - USD ($) $ in Thousands	Feb. 29, 2024	Nov. 30, 2023	Sep. 25, 2023
Foreign Exchange Forward \| Not Designated as Hedging Instrument
Derivative instruments not designated as hedging instruments:
Notional value	$ 1,478,401	$ 2,173,330
Derivative instruments designated as cash flow hedges:
Notional value	1,478,401	2,173,330
Foreign Exchange Forward \| Not Designated as Hedging Instrument \| Other current assets
Derivative instruments not designated as hedging instruments:
Forward foreign currency exchange contracts	10,519	16,078
Derivative instruments designated as cash flow hedges:
Forward foreign currency exchange contracts	10,519	16,078
Foreign Exchange Forward \| Not Designated as Hedging Instrument \| Other accrued liabilities
Derivative instruments not designated as hedging instruments:
Forward foreign currency exchange contracts	9,556	20,856
Derivative instruments designated as cash flow hedges:
Forward foreign currency exchange contracts	9,556	20,856
Foreign Exchange Forward \| Designated as Hedging Instrument
Derivative instruments not designated as hedging instruments:
Notional value	1,013,034	996,667
Derivative instruments designated as cash flow hedges:
Notional value	1,013,034	996,667
Foreign Exchange Forward \| Designated as Hedging Instrument \| Other current assets and other assets
Derivative instruments not designated as hedging instruments:
Forward foreign currency exchange contracts	9,849	14,330
Derivative instruments designated as cash flow hedges:
Forward foreign currency exchange contracts	9,849	14,330
Foreign Exchange Forward \| Designated as Hedging Instrument \| Other accrued liabilities and other long-term liabilities
Derivative instruments not designated as hedging instruments:
Forward foreign currency exchange contracts	4,244	2,724
Derivative instruments designated as cash flow hedges:
Forward foreign currency exchange contracts	4,244	2,724
Cross Currency Interest Rate Contract \| Not Designated as Hedging Instrument
Derivative instruments not designated as hedging instruments:
Notional value			$ 500,000
Derivative instruments designated as cash flow hedges:
Notional value			500,000
Cross Currency Interest Rate Contract \| Designated as Hedging Instrument
Derivative instruments not designated as hedging instruments:
Notional value	471,604	471,604	500,000
Derivative instruments designated as cash flow hedges:
Notional value	471,604	471,604	$ 500,000
Cross Currency Interest Rate Contract \| Designated as Hedging Instrument \| Other Noncurrent Liabilities
Derivative instruments not designated as hedging instruments:
Notional value	12,988	17,219
Derivative instruments designated as cash flow hedges:
Notional value	$ 12,988	$ 17,219

DERIVATIVE INSTRUMENTS - Effect

DERIVATIVE INSTRUMENTS - Effect of Derivative Instruments on AOCI and Statements of Operations (Details) - USD ($) $ in Thousands	3 Months Ended
	Feb. 29, 2024	Feb. 28, 2023
Designated as Hedging Instrument
Derivative [Line Items]
(Losses) gains recognized in OCI	$ (5,348)	$ 10,203
Designated as Hedging Instrument \| Foreign Exchange Forward
Derivative [Line Items]
Gain (loss) reclassified from AOCI into income	577	(7,741)
(Losses) gains recognized in OCI	(5,423)	10,203
Designated as Hedging Instrument \| Cross Currency Interest Rate Contract
Derivative [Line Items]
(Losses) gains recognized in OCI	75	0
Other expense (income), net \| Not Designated as Hedging Instrument \| Foreign Exchange Forward
Derivative [Line Items]
(Loss) gain recognized from foreign exchange forward contracts, net	337	6,225
Selling, general and administrative expenses \| Designated as Hedging Instrument \| Foreign Exchange Forward
Derivative [Line Items]
Gain (loss) reclassified from AOCI into income	123	(1,981)
Cost of revenue for services \| Designated as Hedging Instrument \| Foreign Exchange Forward
Derivative [Line Items]
Gain (loss) reclassified from AOCI into income	$ 454	$ (5,760)

DERIVATIVE INSTRUMENTS - Narrat

DERIVATIVE INSTRUMENTS - Narrative (Details) $ in Thousands	3 Months Ended
DERIVATIVE INSTRUMENTS - Narrative (Details) $ in Thousands	Feb. 29, 2024 USD ($)
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Existing gains expected to be reclassified	$ 5,168

FAIR VALUE MEASUREMENTS (Detail

FAIR VALUE MEASUREMENTS (Details) - USD ($) $ in Thousands	Feb. 29, 2024	Nov. 30, 2023
Liabilities measured at fair value:
Carrying amount	$ 5,034,109	$ 4,939,712
Fair Value, Recurring
Assets measured at fair value:
Cash equivalents	49,236	52,847
Foreign government bond	0	1,853
Liabilities measured at fair value:
Fair value	2,149,981	2,146,554
Carrying amount	2,132,774	2,131,870
Fair Value, Recurring \| Foreign Exchange Forward
Assets measured at fair value:
Forward foreign currency exchange contracts	20,368	30,408
Liabilities measured at fair value:
Forward foreign currency exchange contracts	13,800	23,580
Fair Value, Recurring \| Cross Currency Interest Rate Contract
Liabilities measured at fair value:
Forward foreign currency exchange contracts	12,988	17,219
Fair Value, Recurring \| Contingent Consideration
Liabilities measured at fair value:
Forward foreign currency exchange contracts	31,940	48,600
Fair Value, Recurring \| Level 1
Assets measured at fair value:
Cash equivalents	49,236	52,847
Foreign government bond	0	1,853
Liabilities measured at fair value:
Fair value	0	0
Carrying amount	0	0
Fair Value, Recurring \| Level 1 \| Foreign Exchange Forward
Assets measured at fair value:
Forward foreign currency exchange contracts	0	0
Liabilities measured at fair value:
Forward foreign currency exchange contracts	0	0
Fair Value, Recurring \| Level 1 \| Cross Currency Interest Rate Contract
Liabilities measured at fair value:
Forward foreign currency exchange contracts	0	0
Fair Value, Recurring \| Level 1 \| Contingent Consideration
Liabilities measured at fair value:
Forward foreign currency exchange contracts	0	0
Fair Value, Recurring \| Level 2
Assets measured at fair value:
Cash equivalents	0	0
Foreign government bond	0	0
Liabilities measured at fair value:
Fair value	2,149,981	2,146,554
Carrying amount	0	0
Fair Value, Recurring \| Level 2 \| Foreign Exchange Forward
Assets measured at fair value:
Forward foreign currency exchange contracts	20,368	30,408
Liabilities measured at fair value:
Forward foreign currency exchange contracts	13,800	23,580
Fair Value, Recurring \| Level 2 \| Cross Currency Interest Rate Contract
Liabilities measured at fair value:
Forward foreign currency exchange contracts	12,988	17,219
Fair Value, Recurring \| Level 2 \| Contingent Consideration
Liabilities measured at fair value:
Forward foreign currency exchange contracts	31,940	48,600
Fair Value, Recurring \| Level 3
Assets measured at fair value:
Cash equivalents	0	0
Foreign government bond	0	0
Liabilities measured at fair value:
Fair value	0	0
Carrying amount	0	0
Fair Value, Recurring \| Level 3 \| Foreign Exchange Forward
Assets measured at fair value:
Forward foreign currency exchange contracts	0	0
Liabilities measured at fair value:
Forward foreign currency exchange contracts	0	0
Fair Value, Recurring \| Level 3 \| Cross Currency Interest Rate Contract
Liabilities measured at fair value:
Forward foreign currency exchange contracts	0	0
Fair Value, Recurring \| Level 3 \| Contingent Consideration
Liabilities measured at fair value:
Forward foreign currency exchange contracts	$ 0	$ 0

BORROWINGS - Schedule of Debt (

BORROWINGS - Schedule of Debt (Details) - USD ($) $ in Thousands	Feb. 29, 2024	Nov. 30, 2023	Sep. 25, 2023	Aug. 02, 2023	Apr. 21, 2023
Debt Instrument [Line Items]
Long-term debt, before unamortized debt discount and issuance costs	$ 5,084,686	$ 4,996,087
Less: unamortized debt discount and issuance costs	(50,577)	(56,375)
Long-term debt, net	5,034,109	4,939,712
Other Loans Payable, Current	2,714	2,313
Notes Payable	756,177	762,286
Other Loans Payable	2,509	5,301
2026 Notes
Debt Instrument [Line Items]
Senior Notes	$ 800,000	800,000		$ 800,000
Debt Instrument, Interest Rate, Stated Percentage	6.65%		6.65%	6.65%
2028 Notes
Debt Instrument [Line Items]
Senior Notes	$ 800,000	800,000		$ 800,000
Debt Instrument, Interest Rate, Stated Percentage	6.60%		6.66%	6.60%
2033 Notes
Debt Instrument [Line Items]
Senior Notes	$ 550,000	550,000		$ 550,000
Debt Instrument, Interest Rate, Stated Percentage	6.85%			6.85%
Securitization Facility
Debt Instrument [Line Items]
Credit Facility - Term Loan component	$ 326,000	128,500
Senior Secured Credit Facility \| New Term Loan
Debt Instrument [Line Items]
Credit Facility - Term Loan component	$ 1,850,000	$ 1,950,000			$ 1,850,000

BORROWINGS - Narrative (Details

BORROWINGS - Narrative (Details)						3 Months Ended
BORROWINGS - Narrative (Details)	Sep. 25, 2023 USD ($)	Apr. 21, 2023 USD ($)	Aug. 31, 2022 USD ($)	Jul. 06, 2022 USD ($)	Dec. 27, 2021	Feb. 29, 2024 USD ($)	Feb. 28, 2023 USD ($)	Nov. 30, 2023 USD ($)	Sep. 25, 2023 EUR (€)	Aug. 02, 2023 USD ($)
Webhelp
Debt Instrument [Line Items]
Business Acquisition, Note Payable Consideration	$ 700,000,000
Debt Instrument, Interest Rate, Stated Percentage	2%								2%
Business Acquisition, Note Payable Discount \| €									€ 31,500,000
Business Acquisition, Note Payable Discounted Value	$ 711,830,000								€ 668,500,000
Debt Instrument, Imputed Annual Interest Rate	4.36%								4.36%
Prior Credit Facility - Term Loan
Debt Instrument [Line Items]
Principal payments						$ 100,000,000	$ 25,000,000
Securitization Facility
Debt Instrument [Line Items]
Credit facility, maximum borrowing capacity				$ 500,000,000
Credit Facility - Term Loan component						$ 326,000,000		$ 128,500,000
Securitization Facility \| Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate
Debt Instrument [Line Items]
Basis spread on variable rate				0.80%
Debt Instrument, Basis Spread on Variable Rate, Adjustment				0.10%
Securitization Facility \| Commercial Paper Rate
Debt Instrument [Line Items]
Basis spread on variable rate				0.70%
2026 Notes
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	6.65%					6.65%			6.65%	6.65%
Senior Notes						$ 800,000,000		800,000,000		$ 800,000,000
Debt Conversion, Converted Instrument, Amount	$ 250,000,000
Debt, Weighted Average Interest Rate	5.12%								5.12%
2028 Notes
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	6.66%					6.60%			6.66%	6.60%
Senior Notes						$ 800,000,000		800,000,000		$ 800,000,000
Debt Conversion, Converted Instrument, Amount	$ 250,000,000
Debt, Weighted Average Interest Rate	5.18%								5.18%
2033 Notes
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Stated Percentage						6.85%				6.85%
Senior Notes						$ 550,000,000		550,000,000		$ 550,000,000
Senior Secured Credit Facility
Debt Instrument [Line Items]
Consolidated leverage ratio		3.75
Consolidated interest coverage ratio		3
Senior Secured Credit Facility \| Period Following Acquisition
Debt Instrument [Line Items]
Consolidated leverage ratio		4.25
Senior Secured Credit Facility \| SOFR Rate Loans
Debt Instrument [Line Items]
Basis spread on variable rate		0.10%
Senior Secured Credit Facility \| Base Rate Loans
Debt Instrument [Line Items]
Basis spread on variable rate		1%			1%
Interest rate floor		1%
Senior Secured Credit Facility \| Revolver
Debt Instrument [Line Items]
Credit facility, maximum borrowing capacity		$ 1,042,500,000
Amount outstanding						0		0
Increase in credit facility		500,000,000
Senior Secured Credit Facility \| New Term Loan
Debt Instrument [Line Items]
Credit facility, maximum borrowing capacity		2,144,700,000
Principal payments							$ 25,000,000
Credit Facility - Term Loan component		$ 1,850,000,000				1,850,000,000		$ 1,950,000,000
Proceeds from Lines of Credit	$ 294,702,000
Repayments of Long-Term Debt						$ 100,000,000
Senior Secured Credit Facility \| Prior Credit Facility - Term Loan
Debt Instrument [Line Items]
Quarterly installment amounts			$ 26,250,000
Senior Secured Credit Facility \| Minimum \| SOFR Rate Loans
Debt Instrument [Line Items]
Basis spread on variable rate		1.125%			1.25%
Senior Secured Credit Facility \| Minimum \| Base Rate Loans
Debt Instrument [Line Items]
Basis spread on variable rate		0.125%			0.25%
Senior Secured Credit Facility \| Maximum \| SOFR Rate Loans
Debt Instrument [Line Items]
Basis spread on variable rate		2%			2%
Senior Secured Credit Facility \| Maximum \| Base Rate Loans
Debt Instrument [Line Items]
Basis spread on variable rate		1%			1%
Senior Secured Credit Facility \| Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate \| SOFR Rate Loans
Debt Instrument [Line Items]
Interest rate floor		0%			0%
Senior Secured Credit Facility \| Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate \| Minimum \| SOFR Rate Loans
Debt Instrument [Line Items]
Basis spread on variable rate					0.10%
Senior Secured Credit Facility \| Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate \| Maximum \| SOFR Rate Loans
Debt Instrument [Line Items]
Basis spread on variable rate					0.25%
Senior Secured Credit Facility \| Federal Funds Rate \| Not LIBOR Rate Loans
Debt Instrument [Line Items]
Basis spread on variable rate					0.50%

EARNINGS PER SHARE - Narrative

EARNINGS PER SHARE - Narrative (Details) - shares	Feb. 29, 2024	Nov. 30, 2023	Sep. 25, 2023
Earnings Per Share [Abstract]
Common stock, shares issued (in shares)	67,981,000	67,883,000	14,862,000

EARNINGS PER SHARE - Computatio

EARNINGS PER SHARE - Computation of Earnings Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended
	Feb. 29, 2024	Feb. 28, 2023
Basic earnings per common share:
Net Income (Loss)	$ 52,102	$ 87,870
Less: net income allocated to participating securities	(2,002)	(1,556)
Net income attributable to common stockholders	$ 50,100	$ 86,314
Weighted-average number of common shares - basic (in shares)	65,664	51,150
Basic earnings per common share (in dollars per share)	$ 0.76	$ 1.69
Diluted earnings per common share:
Net Income (Loss)	$ 52,102	$ 87,870
Less: net income allocated to participating securities	(1,998)	(1,546)
Net income attributable to common stockholders	$ 50,104	$ 86,324
Weighted-average number of common shares - basic (in shares)	65,664	51,150
Effect of dilutive securities:
Stock options and restricted stock units	126	326
Weighted-average number of common shares - diluted (in shares)	65,790	51,476
Diluted earnings per common share (in dollars per share)	$ 0.76	$ 1.68

REVENUE (Details)

REVENUE (Details) - USD ($) $ in Thousands	3 Months Ended
REVENUE (Details) - USD ($) $ in Thousands	Feb. 29, 2024	Feb. 28, 2023
Disaggregation of Revenue [Line Items]
Revenue	$ 2,402,748	$ 1,636,404
Technology and consumer electronics
Disaggregation of Revenue [Line Items]
Revenue	665,102	516,608
Communications and media
Disaggregation of Revenue [Line Items]
Revenue	380,165	256,987
Retail, travel and ecommerce
Disaggregation of Revenue [Line Items]
Revenue	583,712	305,504
Banking, financial services and insurance
Disaggregation of Revenue [Line Items]
Revenue	365,422	259,653
Other
Disaggregation of Revenue [Line Items]
Revenue	217,258	119,828
Healthcare
Disaggregation of Revenue [Line Items]
Revenue	$ 191,089	$ 177,824

PENSION AND EMPLOYEE BENEFITS_2

PENSION AND EMPLOYEE BENEFITS PLANS (Details) - USD ($) $ in Thousands	3 Months Ended
	Feb. 29, 2024	Feb. 28, 2023	Nov. 30, 2023
Retirement Benefits [Abstract]
Contributed amount	$ 26,116	$ 22,654
Net benefit costs	3,579	$ 2,934
Plan underfunded amount	$ 82,491		$ 81,813

INCOME TAXES (Details)

INCOME TAXES (Details) - USD ($) $ in Thousands	Feb. 29, 2024	Nov. 30, 2023
Income Tax Disclosure [Abstract]
Unrecognized tax benefits	$ 88,948	$ 87,939
Unrecognized tax benefits that would affect income tax expense if recognized	59,724	52,779
Interest and penalties accrued on unrecognized tax benefits	9,258	$ 8,617
Minimum
Income Tax Contingency [Line Items]
Unrecognized tax benefits decrease amount	46,865
Maximum
Income Tax Contingency [Line Items]
Unrecognized tax benefits decrease amount	$ 47,383

LEASES - Lease Cost (Details)

LEASES - Lease Cost (Details) - USD ($) $ in Thousands	3 Months Ended
LEASES - Lease Cost (Details) - USD ($) $ in Thousands	Feb. 29, 2024	Feb. 28, 2023
Leases [Abstract]
Operating lease cost	$ 68,920	$ 51,760
Short-term lease cost	20,486	4,719
Variable lease cost	10,756	12,331
Sublease income	(492)	(1,363)
Total operating lease cost	$ 99,670	$ 67,447

LEASES - Operating Lease Liabil

LEASES - Operating Lease Liability Maturity (Details) $ in Thousands	Feb. 29, 2024 USD ($)
Leases [Abstract]
Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year	$ 219,100
2025	253,922
2026	188,929
2027	130,847
2028	92,334
Thereafter	153,969
Total payments	1,039,101
Less: imputed interest	156,627
Total present value of lease payments	$ 882,474

LEASES - Operating Lease ROU As

LEASES - Operating Lease ROU Assets and Liabilities (Details) - USD ($) $ in Thousands	Feb. 29, 2024	Nov. 30, 2023
Leases [Abstract]
Operating lease ROU assets	$ 839,337	$ 813,590
Current operating lease liabilities	233,019	229,010
Non-current operating lease liabilities	$ 649,455	$ 623,290
Operating lease, right-of-use asset, statement of financial position	Other assets	Other assets
Operating lease, liability, current, statement of financial position	Other accrued liabilities	Other accrued liabilities
Operating Lease, liability, noncurrent, statement of financial position	Other long-term liabilities	Other long-term liabilities

LEASES - Operating Lease Supple

LEASES - Operating Lease Supplemental Cash Flow Information (Details) - USD ($) $ in Thousands	3 Months Ended
	Feb. 29, 2024	Feb. 28, 2023
Leases [Abstract]
Cash paid for amounts included in the measurement of lease liabilities	$ 75,842	$ 53,825
Non-cash ROU assets obtained in exchange for lease liabilities	$ 87,511	$ 41,394

LEASES - Operating Lease Weight

LEASES - Operating Lease Weighted Average Remaining Lease Term and Discount Rate (Details)	Feb. 29, 2024	Nov. 30, 2023
Leases [Abstract]
Weighted-average remaining lease term (years)	4 years 9 months 7 days	4 years 10 months 17 days
Weighted-average discount rate	6.52%	6.41%

STOCKHOLDERS' EQUITY (Details)

STOCKHOLDERS' EQUITY (Details) - USD ($) $ / shares in Units, $ in Thousands							1 Months Ended	3 Months Ended
	Mar. 26, 2024	Jan. 24, 2024	Sep. 27, 2023	Jun. 28, 2023	Mar. 29, 2023	Jan. 19, 2023	Mar. 31, 2024	Feb. 29, 2024	Feb. 28, 2023	Sep. 30, 2021
Equity [Abstract]
Stock Repurchase Program, Authorized Amount										$ 500,000
Common Stock, Dividends, Per Share, Cash Paid		$ 0.3025	$ 0.3025	$ 0.275	$ 0.275	$ 0.275
Stock Repurchase Program, Remaining Authorized Repurchase Amount								$ 268,452
Stock Repurchased During Period, Value								$ 21,674	$ 10,001
Stock Repurchased During Period, Shares								237,000	71
Subsequent Event [Line Items]
Stock Repurchased During Period, Shares								237,000	71
Stock Repurchased During Period, Value								$ 21,674	$ 10,001
Subsequent Event
Equity [Abstract]
Stock Repurchased During Period, Value							$ 11,964
Stock Repurchased During Period, Shares							184,000
Common stock quarterly dividend declared (in dollars per share)	$ 0.3025
Subsequent Event [Line Items]
Common stock quarterly dividend declared (in dollars per share)	$ 0.3025
Stock Repurchased During Period, Shares							184,000
Stock Repurchased During Period, Value							$ 11,964